FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Rabelo, K
   de Souza, LJ
   Salomao, NG
   Machado, LN
   Pereira, PG
   Portari, EA
   Basilio-de-Oliveira, R
   dos Santos, FB
   Neves, LD
   Morgade, LF
   Provance, DW
   Higa, LM
   Tanuri, A
   de Carvalho, JJ
   Paes, MV
AF Rabelo, Kissila
   de Souza, Luiz Jose
   Salomao, Natalia Gedeao
   Machado, Lara Nascentes
   Pereira, Priscila Gomes
   Portari, Elyzabeth Avvad
   Basilio-de-Oliveira, Rodrigo
   dos Santos, Flavia Barreto
   Neves, Laura Dias
   Morgade, Luciana Faes
   Provance, David William, Jr.
   Higa, Luiza Mendonca
   Tanuri, Amilcar
   de Carvalho, Jorge Jose
   Paes, Marciano Viana
TI Zika Induces Human Placental Damage and Inflammation
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE immune response; histopathology; ultrastructure; cytokines; flavivirus
ID VIRUS-INFECTION; IMMUNE-SYSTEM; GROWTH-FACTOR; BRAIN; BDNF; BARRIER
AB In Brazil, an epidemic of Zika virus (ZIKV) infections was declared in 2015 that coincided with alarming reports of microcephaly in newborns associated with mother infection. Although the virus has placental tropism, changes in the tissue morphology and immunity of infected patients have not yet been elucidated. Here, we investigated the histopathological and ultrastructural changes along with the immunological profile and the BDNF expression in rare placental material. Tissues were obtained in the 2015-2016 Brazilian epidemic, of ten ZIKV-infected patients during pregnancy, five resulting in cases of fetal microcephaly and five non-microcephaly, compared to five non-infected control placentae. Viral antigens were only detected in samples from the ZIKV infected patients. Infected placentae presented histopathological severe damage, while the ultrastructural evaluation showed abnormal organelles, such as clusters of virus-like particles consistent with the ZIKV dimensions. Increased infiltration of CD68(+)and TCD8(+)cells, expression of MMPs, cytokines (IFN-gamma and TNF-alpha) and other immunological mediators (RANTES/CCL5 and VEGFR-2) confirmed excessive inflammation and vascular permeability dysfunction. An evaluation of BDNF showed a decrease that could modulate neuronal damage in the developing fetus. The placental changes caused by ZIKV are not pathognomonic, however, the data provide evidence that this infection leads to severe placental injury.
C1 [Rabelo, Kissila; Pereira, Priscila Gomes; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza, Luiz Jose; Machado, Lara Nascentes] Fac Med Campos, Rio De Janeiro, Brazil.
   [Salomao, Natalia Gedeao; Provance, David William, Jr.; Paes, Marciano Viana] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] Inst Fernandes Figueira Fiocruz, Anat Patol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Rodrigo] Univ Fed Estado Rio De Janeiro, Anat Patol, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Neves, Laura Dias; Morgade, Luciana Faes] CEPLIN Uti Neonatal Nicola Albano, Hosp Geral Dr Beda, Rio De Janeiro, Brazil.
   [Provance, David William, Jr.] Fiocruz MS, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil.
   [Higa, Luiza Mendonca; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Lab Virol Mol, Rio De Janeiro, Brazil.
RP Rabelo, K (corresponding author), Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.; Paes, MV (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
EM kissilarabelo91@gmail.com; marciano@ioc.fiocruz
RI ; Provance, David/D-5294-2013
OI Rabelo, Kissila/0000-0001-7579-7788; Provance,
   David/0000-0002-9824-0672; Santos, Flavia/0000-0002-1309-5366
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308780/2015-9]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/110.511/2014,
   E-26/010.001.498/2016, E26/202.003/2016, E-26/202.659/2019]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This work was supported by the CNPq (308780/2015-9) and the FAPERJ
   (E-26/110.511/2014, E-26/010.001.498/2016, E26/202.003/2016, and
   E-26/202.659/2019). To Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) and CNPq for the students fellowships. The
   funders had no role in the study design, data collection, analysis and
   decision to publish, or preparation of the manuscript.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Beaufrere A, 2019, BRAIN PATHOL, V29, P114, DOI 10.1111/bpa.12644
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, 2018, EP B INT MON GROWTH
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chiu CF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00214
   Choudhury RH, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13054
   Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Franczyk M, 2017, PLACENTA, V50, P19, DOI 10.1016/j.placenta.2016.12.014
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes JP, 2018, GENES BRAIN BEHAV, V17, P107, DOI 10.1111/gbb.12403
   Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9
   Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lima MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01928
   Lum FM, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1082
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Oefner CM, 2015, PLACENTA, V36, P59, DOI 10.1016/j.placenta.2014.10.012
   Petitt M, 2017, PHYSIOL BEHAV, V176, P139, DOI [10.1016/j.physbeh.2017.03.040, DOI 10.1016/J.PHYSBEH.2017.03.040]
   Pinar H, 2014, OBSTET GYNECOL, V123, P325, DOI 10.1097/AOG.0000000000000100
   Pomar L, 2020, ULTRASOUND OBST GYN, V56, P740, DOI 10.1002/uog.21936
   Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rosenberg A, 2016, COLL AM PATHOL, V1, P1, DOI [10.5858/arpa.2016-0401-OA, DOI 10.5858/ARPA.2016-0401-OA]
   Santos GR, 2020, INT J GYNECOL PATHOL, V39, P157, DOI 10.1097/PGP.0000000000000586
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454
   Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tometten M, 2005, CHEM IMMUNOL ALLERGY, V89, P135, DOI 10.1159/000087962
   Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
   Zulu MZ, 2019, J INNATE IMMUN, V11, P447, DOI 10.1159/000497416
NR 54
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 1
PY 2020
VL 11
AR 2146
DI 10.3389/fimmu.2020.02146
PG 15
WC Immunology
SC Immunology
GA NQ2BF
UT WOS:000570669900001
PM 32983175
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Adachi, K
   Romero, T
   Nielsen-Saines, K
   Pone, S
   Aibe, M
   de Aguiar, EB
   Sim, M
   Brasil, P
   Zin, A
   Tsui, I
   Gaw, SL
   Halai, UA
   Vasconcelos, Z
   Pereira, JP
   Salles, TS
   Barbosa, CN
   Portari, E
   Cherry, JD
   Pone, M
   Moreira, ME
AF Adachi, Kristina
   Romero, Tahmineh
   Nielsen-Saines, Karin
   Pone, Sheila
   Aibe, Mitsue
   de Aguiar, Elisa Barroso
   Sim, Myung
   Brasil, Patricia
   Zin, Andrea
   Tsui, Irena
   Gaw, Stephanie L.
   Halai, Umme-Aiman
   Vasconcelos, Zilton
   Pereira, Jose Paulo
   Salles, Tania Saad
   Barbosa, Claudia Neves
   Portari, Elyzabeth
   Cherry, James D.
   Pone, Marcos
   Moreira, Maria Elisabeth
TI Early Clinical Infancy Outcomes for Microcephaly and/or Small for
   Gestational Age Zika-Exposed Infants
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; congenital Zika syndrome; microcephaly; proportional microcephaly;
   small for gestational age (SGA)
ID LINKED IMMUNOSORBENT ASSAYS; VIRUS-INFECTION; BRAZIL; CYTOMEGALOVIRUS;
   EPIDEMIC; GROWTH; STATE; IGM
AB Background. Zika-exposed infants with microcephaly (proportional or disproportional) and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.Antenatal Zika virus (ZIKV) exposure may lead to adverse infant outcomes including microcephaly and being small for gestational age (SGA). ZIKV-exposed infants with a diagnosis of microcephaly (proportional [PM] or disproportional [DM]) or SGA at birth were evaluated with anthropometric measurements and health outcomes.
   Methods. Infants had laboratory-confirmed ZIKV exposure in Brazil. PM, DM, or SGA classification was based on head circumference and weight. First-year growth parameters and clinical outcomes were recorded with analyses performed.
   Results. Among the 156 ZIKV-exposed infants, 14 (9.0%) were SGA, 13 (8.3%) PM, 13 (8.3%) DM, and 116 (74.4%) were neither SGA nor had microcephaly (NSNM). High rates of any neurologic, ophthalmologic, and hearing abnormalities were observed for PM (100%), DM (100%), and SGA (42.9%) vs NSNM infants (18.3%; P <.001); odds ratio [OR], 3.4 (95% confidence interval [CI], 1.1-10.7) for SGA vs NSNM. Neuroimaging abnormalities were seen in 100% of PM and DM and in 42.9% of SGA vs NSNM infants 16%; (P <.001); OR 3.9 (95% CI, 1.2-12.8) for SGA vs NSNM. Growth rates by z score, particularly for microcephaly infants, were poor after birth but showed improvement beyond 4 months of life.
   Conclusions. ZIKV-exposed infants with microcephaly (PM and DM) had similarly high rates of adverse outcomes but showed improvement in growth measurements beyond 4 months of life. While SGA infants had fewer adverse outcomes compared with microcephaly infants, notable adverse outcomes were observed in some; their odds of having adverse outcomes were 3 to 4 times greater compared to NSNM infants.
C1 [Adachi, Kristina; Nielsen-Saines, Karin; Cherry, James D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.
   [Romero, Tahmineh; Sim, Myung] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA.
   [Pone, Sheila; Aibe, Mitsue; de Aguiar, Elisa Barroso; Zin, Andrea; Vasconcelos, Zilton; Pereira, Jose Paulo; Salles, Tania Saad; Barbosa, Claudia Neves; Portari, Elyzabeth; Pone, Marcos; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol, San Francisco, CA USA.
   [Halai, Umme-Aiman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
RP Moreira, ME (corresponding author), Inst Fernandes Figueira IFF, Ave Rui Barbosa 716, BR-22420040 Flamengo Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
OI Moura Pone, Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the National Institutes of Health
   (NIH)/National Center for Advancing Translational Science of the
   University of California-Los Angeles Clinical and Translational Science
   Institute [AI129847-01, UL1TR001881]; Thrasher Research Fund [20164370];
   UK Department for International Development; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [K08AI141728,
   K08AI141728] Funding Source: NIH RePORTER
FX The work was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01), the National Institute of Allergy and
   Infectious Diseases (AI28697, AI1259534-01) and the National Eye
   Institute (AI129847-01) of the National Institutes of Health
   (NIH)/National Center for Advancing Translational Science of the
   University of California-Los Angeles Clinical and Translational Science
   Institute (UL1TR001881), Thrasher Research Fund (20164370), and the UK
   Department for International Development.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, ZIK MAC ELISA, V2019
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MDC, 2020, BRAZ J OTORHINOLAR, V86, P513, DOI 10.1016/j.bjorl.2016.06.001
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   PAHO/WHO, 2017, ZIK CAS CONG SYNDR A
   PAHO WHO, 2016, REG ZIK EP UPD AM
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   PRIMHAK RA, 1982, CLIN PEDIATR, V21, P417, DOI 10.1177/000992288202100705
   Simonazzi G, 2014, PRENATAL DIAG, V34, P765, DOI 10.1002/pd.4362
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yamamoto R, 2013, J OBSTET GYNAECOL RE, V39, P653, DOI 10.1111/j.1447-0756.2012.02012.x
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 26
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2020
VL 70
IS 12
BP 2663
EP 2672
DI 10.1093/cid/ciz704
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA MO4RV
UT WOS:000551516200037
PM 31346616
OA Green Published
DA 2020-12-01
ER

PT J
AU Aguiar, RS
   Pohl, F
   Morais, GL
   Nogueira, FCS
   de Carvalho, JB
   Guida, L
   Arge, LWP
   Melo, A
   Moreira, MEL
   Cunha, DP
   Gomes, L
   Portari, EA
   Velasquez, E
   Melani, RD
   Pezzuto, P
   de Castro, FL
   Geddes, VEV
   Gerber, AL
   Azevedo, GS
   Schamber-Reis, BL
   Goncalves, AL
   Junqueira-de-Azevedo, I
   Nishiyama, MY
   Ho, P
   Schanoski, A
   Schuch, V
   Tanuri, A
   Chimelli, L
   Vasconcelos, ZFM
   Domont, GB
   Vasconcelos, ATR
   Nakaya, HI
AF Aguiar, Renato S.
   Pohl, Fabio
   Morais, Guilherme L.
   Nogueira, Fabio C. S.
   de Carvalho, Joseane B.
   Guida, Leticia
   Arge, Luis W. P.
   Melo, Adriana
   Moreira, Maria E. L.
   Cunha, Daniela P.
   Gomes, Leonardo
   Portari, Elyzabeth A.
   Velasquez, Erika
   Melani, Rafael D.
   Pezzuto, Paula
   de Castro, Fernanda L.
   Geddes, Victor E. V.
   Gerber, Alexandra L.
   Azevedo, Girlene S.
   Schamber-Reis, Bruno L.
   Goncalves, Alessandro L.
   Junqueira-de-Azevedo, Inacio
   Nishiyama Jr, Milton Y.
   Ho, Paulo
   Schanoski, Alessandra
   Schuch, Viviane
   Tanuri, Amilcar
   Chimelli, Leila
   Vasconcelos, Zilton F. M.
   Domont, Gilberto B.
   Vasconcelos, Ana T. R.
   Nakaya, Helder, I
TI Molecular alterations in the extracellular matrix in the brains of
   newborns with congenital Zika syndrome
SO SCIENCE SIGNALING
LA English
DT Article
ID VIRUS-INFECTION; RNA-SEQ; COLLAGEN; MUTATIONS; DATABASE; VISUALIZATION;
   POLYMORPHISM; DISRUPTION; PROTEINS; REGIONS
AB Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.
C1 [Aguiar, Renato S.; Pezzuto, Paula; de Castro, Fernanda L.; Geddes, Victor E. V.; Goncalves, Alessandro L.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Pohl, Fabio; Schuch, Viviane; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Morais, Guilherme L.; de Carvalho, Joseane B.; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.
   [Nogueira, Fabio C. S.; Velasquez, Erika; Melani, Rafael D.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.
   [Nogueira, Fabio C. S.] Univ Fed Rio de Janeiro, Inst Chem, LADETEC, Lab Prote, Rio De Janeiro, Brazil.
   [Guida, Leticia; Moreira, Maria E. L.; Cunha, Daniela P.; Gomes, Leonardo; Portari, Elyzabeth A.; Vasconcelos, Zilton F. M.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Melo, Adriana; Azevedo, Girlene S.] Inst Pesquisa Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Schamber-Reis, Bruno L.] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [Junqueira-de-Azevedo, Inacio; Nishiyama Jr, Milton Y.] Butantan Inst, Special Lab Appl Toxinol, Sao Paulo, Brazil.
   [Ho, Paulo; Schanoski, Alessandra] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Vasconcelos, ATR (corresponding author), LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.; Domont, GB (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.; Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
EM chimelli@hucff.ufrj.br; zilton.vasconcelos@iff.fiocruz.br;
   gilbertodomont@gmail.com; atrv@lncc.br; hnakaya@usp.br
RI NOGUEIRA, FABIO CESAR SOUSA/G-9580-2011; Nakaya, Helder I/A-1397-2010;
   Nakaya, Helder/AAF-1738-2020; Center of Toxins,
   Immune-response/J-5731-2015; Junqueira-de-Azevedo, Inacio L.
   M./H-5239-2011; Nishiyama Junior, Milton/H-4002-2013; Aguiar,
   Renato/G-3542-2015
OI NOGUEIRA, FABIO CESAR SOUSA/0000-0001-5507-7142; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108;
   Junqueira-de-Azevedo, Inacio L. M./0000-0003-4491-0180; Nishiyama
   Junior, Milton/0000-0002-2410-0562; Guida, Leticia/0000-0003-3543-1532;
   Arge, Luis Willian Pacheco/0000-0002-0109-4809; Pohl,
   Fabio/0000-0003-1695-4936; Aguiar, Renato/0000-0001-5180-3717;
   /0000-0002-2034-0294; Geddes, Victor/0000-0002-0723-3873
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440900/2016-6, 313662/2017-7, 440613/2016-7, 303170/2017-4]; CAPESCAPES
   [88881.130757/2016-01, 001, 88887.130697]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [01.16.0078.00]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, 2013/08216-2];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/202.650/2018, 26/202.903/20]
FX This research was supported by CNPq (grant no. 440900/2016-6), CAPES
   (grant no. 88881.130757/2016-01), and FINEP (grant no. 01.16.0078.00).
   H.I.N. is supported by CNPq (313662/2017-7) and the Sao Paulo Research
   Foundation (FAPESP; grants 2017/50137-3, 2012/19278-6, 2018/14933-2,
   2018/21934-5, and 2013/08216-2). F.L.d.C., V.E.V.G., J.B.C., and
   L.W.P.A. are funded by CAPES (grant 001). G.B.D. has financial support
   from grants 88887.130697 (CAPES) and 440613/2016-7 (CNPq). F.C.S.N. is
   supported by FAPERJ (E-26/202.650/2018). A.T.R.V. is supported by CNPq
   (303170/2017-4) and FAPERJ (26/202.903/20).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954
   Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen Y, 2017, INT J CLIN EXP MED, V10, P14904
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dittrich R, 2007, NEUROLOGY, V68, P2120, DOI 10.1212/01.wnl.0000264892.92538.a9
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faqeih E, 2009, AM J MED GENET A, V149A, P461, DOI 10.1002/ajmg.a.32653
   Fernandez-Calle R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0823-8
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gorshkov V, 2015, ANAL CHEM, V87, P6319, DOI 10.1021/acs.analchem.5b01166
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HIPC-CHI Signatures Project Team; HIPC-I Consortium, 2017, SCI IMMUNOL, V2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797
   Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larroche J.-C., 1977, DEV PATHOLOGY NEONAT, Vxviii
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024
   Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026
   Maness PF, 2007, NAT NEUROSCI, V10, P263, DOI 10.1038/nn0207-263b
   Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007
   Plotkin Horacio, 2004, BMC Pediatr, V4, P16, DOI 10.1186/1471-2431-4-16
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004
   Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907
   Schiela B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02177
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]
   Useche YM, 2019, J INFECT PUBLIC HEAL, V12, P43, DOI 10.1016/j.jiph.2018.08.009
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   van der Velde KJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1141-7
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weng YC, 2012, ANN NEUROL, V71, P470, DOI 10.1002/ana.22682
   Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Zhu Zhe, 2017, J Exp Med, V214, P3145, DOI 10.1084/jem.2017109309122017c
   Zou YQ, 2014, HUM MOL GENET, V23, P2339, DOI 10.1093/hmg/ddt627
NR 86
TC 1
Z9 1
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 9
PY 2020
VL 13
IS 635
AR eaay6736
DI 10.1126/scisignal.aay6736
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LY4UD
UT WOS:000540523900001
PM 32518143
DA 2020-12-01
ER

PT J
AU Sobhani, NC
   Avvad-Portari, E
   Nascimento, ACM
   Machado, HN
   Lobato, DSS
   Pereira, JP
   Esquivel, MS
   Vasconcelos, ZC
   Zin, AA
   Tsui, I
   Adachi, K
   Brickley, EB
   Fisher, SJ
   Nielsen-Saines, K
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Sobhani, Nasim C.
   Avvad-Portari, Elyzabeth
   Nascimento, Aline C. M.
   Machado, Heloisa N.
   Lobato, Daniel S. S.
   Pereira, Jose Paulo
   Esquivel, Mikaela S.
   Vasconcelos, Zilton C.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Brickley, Elizabeth B.
   Fisher, Susan J.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Discordant Zika Virus Findings in Twin Pregnancies Complicated by
   Antenatal Zika Virus Exposure: A Prospective Cohort
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome; perinatal infection; TORCH infection; twin;
   vertical transmission
ID PLACENTAL PATHOLOGY; INFECTION; CELLS; INFANTS
AB Background. There are limited data on the natural history of antenatal Zika virus (ZIKV) exposure in twin pregnancies, especially regarding intertwin concordance of prenatal, placental, and infant outcomes.
   Methods. This prospective cohort study included twin pregnancies referred to a single institution from September 2015 to June 2016 with maternal ZIKV. Polymerase chain reaction (PCR) testing of maternal, placental, and neonatal samples was performed. Prenatal ultrasounds were completed for each twin, and histomorphologic analysis was performed for each placenta. Abnormal neonatal outcome was defined as abnormal exam and/or abnormal imaging. Two- to three-year follow-up of infants included physical exams, neuroimaging, and Bayley-III developmental assessment.
   Results. Among 244 pregnancies, 4 twin gestations without coinfection were identified. Zika virus infection occurred at 16-33 weeks gestation. Zika virus PCR testing revealed discordance between dichorionic twins, between placentas in a dichorionic pair, between portions of a monochorionic placenta, and between a neonate and its associated placenta. Of the 8 infants, 3 (38%) had an abnormal neonatal outcome. Of 6 infants with long-term follow-up, 3 (50%) have demonstrated ZIKV-related abnormalities.
   Conclusions. Neonatal PCR testing, placental findings, and infant outcomes can be discordant between co-twins with antenatal ZIKV exposure. These findings demonstrate that each twin should be evaluated independently for vertical transmission.
C1 [Sobhani, Nasim C.; Esquivel, Mikaela S.; Fisher, Susan J.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Avvad-Portari, Elyzabeth; Nascimento, Aline C. M.; Machado, Heloisa N.; Lobato, Daniel S. S.; Pereira, Jose Paulo; Vasconcelos, Zilton C.; Zin, Andrea A.; Brasil, Patricia; Moreira, Maria E.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556 16HSE, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Brickley, Elizabeth/U-3625-2017
OI Brickley, Elizabeth/0000-0003-0280-2288
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [K08AI141728]; Foundation for the Society of
   MaternalFetal Medicine Queenan Fellowship for Global Health; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R21AI28697,
   R21AI129534]; National Eye Institute (NEI)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318]; Brazilian Ministry of
   Health; Wellcome TrustWellcome Trust [205377/Z/16/Z]; UK's Department
   for International Development [205377/Z/16/Z]; European UnionEuropean
   Union (EU) [734584]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K08AI141728, K08AI141728] Funding Source: NIH RePORTER
FX This work was funded by the following: National Institute of Allergy and
   Infectious Diseases (NIAID) (K08AI141728) and the Foundation for the
   Society of Maternal Fetal Medicine Queenan Fellowship for Global Health
   (to S. L. G.); generous support from Marc and Lynne Benioff (to S. J.
   F.); National Institute of Allergy and Infectious Diseases (R21AI28697
   and R21AI129534) and National Eye Institute (NEI) (R21EY028318) (to K.
   N.-S.); the Brazilian Ministry of Health (to P. B. and M. E. M.);
   Wellcome Trust and the UK's Department for International Development
   (205377/Z/16/Z; to M. E. M. and E. B.); the European Union's Horizon
   2020 Research and Innovation Programme under ZikaPLAN grant agreement
   number 734584 and FAPERJ (to M. E. M.); and the Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ (EAP).
CR AHLFORS K, 1988, EARLY HUM DEV, V18, P125, DOI 10.1016/0378-3782(88)90049-7
   Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dickinson JE, 2006, TWIN RES HUM GENET, V9, P456, DOI 10.1375/twin.9.3.456
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010
   Higgins M, 2011, PEDIATR DEVEL PATHOL, V14, P273, DOI 10.2350/10-07-0872-OA.1
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Pereira L, 2017, PLACENTA, V59, pS8, DOI 10.1016/j.placenta.2017.04.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056
   Reyes L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02628
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Thapa R, 2009, INDIAN J PEDIATR, V76, P1069, DOI 10.1007/s12098-009-0208-9
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 27
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2020
VL 221
IS 11
BP 1838
EP 1845
DI 10.1093/infdis/jiz629
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LU0MN
UT WOS:000537458000014
PM 31773163
DA 2020-12-01
ER

PT J
AU Messias, CV
   Loss-Morais, G
   de Carvalho, JB
   Gonzalez, MN
   Cunha, DP
   Vasconcelos, Z
   Arge, LWP
   Farias-de-Oliveira, DA
   Gerber, AL
   Portari, EA
   Ferreira, N
   Raphael, LMS
   Bonaldo, MC
   Riederer, I
   Moreira, MEL
   Cotta-de-Almeida, V
   Vasconcelos, ATR
   Mendes-da-Cruz, DA
   Savino, W
AF Messias, Carolina V.
   Loss-Morais, Guilherme
   de Carvalho, Joseane Biso
   Gonzalez, Mariela N.
   Cunha, Daniela P.
   Vasconcelos, Zilton
   Arge, Luis W. P.
   Farias-de-Oliveira, Desio A.
   Gerber, Alexandra L.
   Portari, Elyzabeth A.
   Ferreira, Nilma
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Riederer, Ingo
   Lopes Moreira, Maria E.
   Cotta-de-Almeida, Vinicius
   Vasconcelos, Ana T. R.
   Mendes-da-Cruz, Daniella A.
   Savino, Wilson
TI Zika virus targets the human thymic epithelium
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; NONCODING RNA; MEDIATED INTERACTIONS; CELLS;
   INFECTION; THYMOCYTES; MIGRATION; DIFFERENTIATION; EXPRESSION; MOLECULES
AB Previous work showed that the thymus can be infected by RNA viruses as HIV and HTLV-1. We thus hypothesized that the thymus might also be infected by the Zika virus (ZIKV). Herein we provide compelling evidence that ZIKV targets human thymic epithelial cells (TEC) in vivo and in vitro. ZIKV-infection enhances keratinization of TEC, with a decrease in proliferation and increase in cell death. Moreover, ZIKV modulates a high amount of coding RNAs with upregulation of genes related to cell adhesion and migration, as well as non-coding genes including miRNAs, circRNAs and lncRNAs. Moreover, we observed enhanced attachment of lymphoblastic T-cells to infected TEC, as well as virus transfer to those cells. Lastly, alterations in thymuses from babies congenitally infected were seen, with the presence of viral envelope protein in TEC. Taken together, our data reveals that the thymus, particularly the thymic epithelium, is a target for the ZIKV with changes in the expression of molecules that are relevant for interactions with developing thymocytes.
C1 [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.
   [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Loss-Morais, Guilherme; de Carvalho, Joseane Biso; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] Natl Lab Sci Comp, Bioinformat Lab, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol Flavivirus, Rio De Janeiro, Brazil.
   [Cunha, Daniela P.; Vasconcelos, Zilton; Portari, Elyzabeth A.; Ferreira, Nilma; Lopes Moreira, Maria E.] Fundacao Oswaldo Cruz, Lab High Complex, Fernandes Figueira Natl Inst Hlth Mother Child &, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.; Vasconcelos, ATR (corresponding author), Natl Lab Sci Comp, Bioinformat Lab, Rio De Janeiro, Brazil.
EM atrv@lncc.br; daniella@ioc.fiocruz.br; wilson.savino@fiocruz.br
RI ; Riederer, Ingo/O-1444-2017; Mendes-da-Cruz, Daniella/E-7875-2016
OI Cunha, Daniela/0000-0002-5954-6054; Riederer, Ingo/0000-0001-7171-9977;
   Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Arge, Luis Willian
   Pacheco/0000-0002-0109-4809
FU Brazilian Funding Agency for Studies and Projects (FINEP)
   [01.16.0078.00]; Brazilian National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [303170/2017-4, 306699/2018-4,
   307720/2016-0]; Carlos Chagas Filho Foundation for Funding Research in
   the State of Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.826/2018]; Oswaldo Cruz Foundation (Fiocruz); National
   Laboratory for Scientific Computation; Coordination of Superior Level
   Staff Improvement (CAPES) -Brazil [001]; Mercosur Fund for Structural
   Convergence (FOCEM) [03/11]; Program of Preventing and Combating the
   Zika Virus, MCTIC/FNDCT -CNPq/MEC-CAPES/MS-Decit [426767/2018-7,
   88881.130684/2016-01];  [23038.010041/2013-13];  [465489/2014-1]
FX The human postnatal TEC line was kindly provided by Dr. Maria Luiza
   Toribio (Universidad Autonoma de Madrid, Madrid, Spain). The mouse
   monoclonal 4G2 antibody (anti-flavivirus) was gently provided by the
   Laboratory of Monoclonal Antibody Technology from Bio-Manguinhos
   (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil). The authors thank
   Raquel de Souza Martins for confocal analysis assistance. This work was
   funded by Brazilian Funding Agency for Studies and Projects (FINEP)
   #01.16.0078.00; Brazilian National Council for Scientific and
   Technological Development (CNPq) ATRV supported by #303170/2017-4, WS by
   #306699/2018-4, DAMC by #307720/2016-0; Carlos Chagas Filho Foundation
   for Funding Research in the State of Rio de Janeiro (Faperj) ATRV
   supported by #E-26/202.826/2018; the Oswaldo Cruz Foundation (Fiocruz)
   and National Laboratory for Scientific Computation; Coordination of
   Superior Level Staff Improvement (CAPES) -Brazil -Finance Code 001 and
   GLM, JBC and LWPA supported #23038.010041/2013-13; Mercosur Fund for
   Structural Convergence (FOCEM, Mercosur #03/11) and the Program of
   Preventing and Combating the Zika Virus, MCTIC/FNDCT
   -CNPq/MEC-CAPES/MS-Decit (Grants 426767/2018-7 and 88881.130684/2016-01
   for MCB). This work was developed in the framework of the Brazilian
   National Institute of Science and Technology on Neuroimmunomodulation
   (INCT-NIM) WS supported by #465489/2014-1.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Azouz F, 2019, VIRUSES, V11, P1
   Bertoni A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020485
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Braun J, 1996, VIROLOGY, V225, P413, DOI 10.1006/viro.1996.0617
   Bunting MD, 2014, IMMUNOL CELL BIOL, V92, P489, DOI 10.1038/icb.2014.14
   Cadena C, 2017, MOL CELL, V67, P163, DOI 10.1016/j.molcel.2017.07.005
   Carnero E, 2016, EMBO REP, V17, P1013, DOI 10.15252/embr.201541763
   Barros LRC, 2017, IMMUNOBIOLOGY, V222, P1053, DOI 10.1016/j.imbio.2017.08.001
   Cava C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020274
   Dairaghi DJ, 1998, BLOOD, V91, P2905, DOI 10.1182/blood.V91.8.2905.2905_2905_2913
   Dejana E, 2013, J CELL SCI, V126, P2545, DOI 10.1242/jcs.124529
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI 10.1093/nar/gkx1132
   FERNANDEZ E, 1994, BLOOD, V83, P3245
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hale LP, 2004, J IMMUNOL, V172, P617, DOI 10.4049/jimmunol.172.1.617
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264
   Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LE PT, 1993, INT J CLIN LAB RES, V23, P56, DOI 10.1007/BF02592284
   Limonta D., 2018, VIRUSES, V10, P1
   Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2
   Liu L, 2019, CELL DEATH DIFFER, V26, P2607, DOI 10.1038/s41418-019-0324-7
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lyu Q, 2019, P NATL ACAD SCI USA, V116, P546, DOI 10.1073/pnas.1810729116
   MAGUERSATTA V, 1995, BLOOD, V86, P1444, DOI 10.1182/blood.V86.4.1444.bloodjournal8641444
   Manca N, 2002, J ACQ IMMUN DEF SYND, V29, P300, DOI 10.1097/00126334-200203010-00012
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Messias CV, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4622-y
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Moreira-Ramos K, 2011, MEM I OSWALDO CRUZ, V106, P759, DOI 10.1590/S0074-02762011000600018
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nishitsuji H, 2016, P NATL ACAD SCI USA, V113, P10388, DOI 10.1073/pnas.1525022113
   Paessens LC, 2008, MOL IMMUNOL, V45, P42, DOI 10.1016/j.molimm.2007.05.016
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Ocampo JSP, 2008, CELL IMMUNOL, V254, P1, DOI 10.1016/j.cellimm.2008.06.005
   Ribeiro-Carvalho MM, 2007, SCAND J IMMUNOL, V66, P17, DOI 10.1111/j.1365-3083.2007.01928.x
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V10, P142, DOI 10.1159/000067175
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1988, ENDOCRINOLOGY, V123, P2557, DOI 10.1210/endo-123-5-2557
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Savino W, 2016, NAT REV ENDOCRINOL, V12, P77, DOI 10.1038/nrendo.2015.168
   Savino W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00579
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SINGER KH, 1990, J IMMUNOL, V144, P2931
   Singh P.K., 2018, SCI REP, V8, P1, DOI [10.1038/s41598-018-29329-2., DOI 10.1038/S41598-018-29329-2.]
   Strange DP, 2018, SCI REP, V8, P1
   Wang M, 2017, INT J BIOL SCI, V13, P1497, DOI 10.7150/ijbs.22531
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zamarchi R, 2002, CLIN EXP IMMUNOL, V127, P321, DOI 10.1046/j.1365-2249.2002.01775.x
   Zhang CL, 2018, AM J TRANSL RES, V10, P4193
   Zhao JM, 2018, NEOPLASMA, V65, P779, DOI 10.4149/neo_2018_171130N778
NR 66
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 28
PY 2020
VL 10
IS 1
AR 1378
DI 10.1038/s41598-020-58135-y
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NE8OR
UT WOS:000562865600009
PM 31992777
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Crispi, CP
   Crispi, CP
   Mendes, FLF
   de Andrade, CM
   Cardeman, L
   de Nadai, N
   Portari, EA
   Fonseca, MD
AF Crispi, Claudio Peixoto, Jr.
   Crispi, Claudio Peixoto
   Fernandes Mendes, Fernando Luis
   de Andrade, Claudio Moura, Jr.
   Cardeman, Leon
   de Nadai Filho, Nilton
   Portari, Elyzabeth Avvad
   Fonseca, Marlon de Freitas
TI Practical considerations in the use of a porcine model (Sus scrofa
   domesticus) to assess prevention of postoperative peritubal adhesions
SO PLOS ONE
LA English
DT Article
ID ABDOMINAL ADHESIONS; REDUCTION; BARRIER
AB Infertility has been a common postoperative problem caused by peritoneal adhesions. Since several prophylactic agents have recently shown promising preliminary results, more complete studies comparing their real efficacy and safety are needed urgently. The aim of this study was to investigate and describe practical considerations of a porcine model that can be used to assess such prophylactic agents. First, 10 healthy 51/2 months old female pigs (24.3-31.3 Kg) underwent a standardized laparoscopy to provoke peritubal adhesion formation without prophylactic agents. After 30 days, a second-look laparoscopy was performed to evaluate adhesions and perform adnexectomy for histopathological evaluation. Adhesions at different sites were classified by grade, for which the scores range from 0 (no adhesion) to 3 (very strong vascularized adhesions), and also by area, with scores ranging from 0 (no adhesion) to 4 (> 75% of the injured area). The histopathological evaluation of the distal uterine horns, oviducts and ovaries were compared with those from a control group of six healthy pigs with no previous surgery. Biological samples were collected to assess vitality, inflammation and renal, hepatic and hematopoietic systems. There were small (but significant) changes in serum albumin (P = 0.07), globulin (P = 0.07), C-reactive protein (P = 0.011), fibrinogen (P = 0.023) and bilirubin (P<0.01) after 30 days, but all values were within the normal range. No inflammation or abscess formation was observed, but different degrees of adhesion were identified. The estimated occurrence of adhesion (scores > 0) and of strong / very strong adhesion (scores > 1) was 75% (95% CI: 55-94.9) and 65% (95% CI: 45-85), respectively. The porcine model represents a useful animal platform that can be used to test the efficacy and safety of candidate prophylactic agents intended to prevent postoperative peritubal adhesions formation. We present several practical considerations and measures that can help to minimize animal suffering and avoid problems during such experiments.
C1 [Crispi, Claudio Peixoto, Jr.; Crispi, Claudio Peixoto; de Andrade, Claudio Moura, Jr.; de Nadai Filho, Nilton] SUPREMA Univ, Surg Training Ctr, Juiz De Fora, MG, Brazil.
   [Crispi, Claudio Peixoto, Jr.; Crispi, Claudio Peixoto; de Nadai Filho, Nilton] Crispi Inst Minimally Invas Surg, Rio De Janeiro, RJ, Brazil.
   [Fernandes Mendes, Fernando Luis] UNIFESO Univ, Dept Surg & Anesthesia, Coll Vet Med, Rio De Janeiro, Brazil.
   [Cardeman, Leon] Leon Cardeman Lab Cytopathol, Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth Avvad; Fonseca, Marlon de Freitas] Fundacao Oswaldo Cruz, Dept Womens Hlth, Fernandes Figueira Natl Inst Women Children & You, Rio De Janeiro, RJ, Brazil.
RP Crispi, CP (corresponding author), SUPREMA Univ, Surg Training Ctr, Juiz De Fora, MG, Brazil.; Crispi, CP (corresponding author), Crispi Inst Minimally Invas Surg, Rio De Janeiro, RJ, Brazil.
EM claudin.jr@gmail.com
FU DMC Importacao e Exportacao de Equipamentos Ltda
FX This study was supported by DMC Importacao e Exportacao de Equipamentos
   Ltda which provided advanced medical devices and equipment for surgical
   procedures through its product development centers and manufacturing
   facilities in Sao Carlos -SP, Brazil, and by Instituto Crispi de
   Cirurgias Minimamente Invasivas (Rio de Janeiro -RJ, Brazil). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ahmad G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006583.pub4
   Ahmad G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001298.pub4
   Ali S, 2018, JCPSP-J COLL PHYSICI, V28, P663, DOI 10.29271/jcpsp.2018.09.663
   Askari VR, 2018, BIOMED PHARMACOTHER, V99, P346, DOI 10.1016/j.biopha.2018.01.068
   Charboneau AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207797
   Cheung JPY, 2009, ASIAN J SURG, V32, P180, DOI 10.1016/S1015-9584(09)60392-4
   Choi GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33145-z
   Coccolini F, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-6
   Crispi CP, 2018, JSLS-J SOC LAPAROEND, V22, DOI 10.4293/JSLS.2018.00042
   de Oliveira FMM, 2012, TRATADO ENDOSCOPIA G, P130
   de Wilde RL, 2018, J MINIM INVAS GYN, V25, P1311, DOI 10.1016/j.jmig.2018.05.018
   Diamond MP, 2016, FERTIL STERIL, V106, P994, DOI 10.1016/j.fertnstert.2016.08.029
   Eickhoff RM, 2018, J SURG RES, V222, P85, DOI 10.1016/j.jss.2017.09.047
   Ferland R, 2001, HUM REPROD, V16, P2718, DOI 10.1093/humrep/16.12.2718
   Han ES, 2017, CURR OPIN OBSTET GYN, V29, P266, DOI 10.1097/GCO.0000000000000372
   Hein S, 2018, WORLD J UROL, V36, P673, DOI 10.1007/s00345-018-2188-8
   Hindocha A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011254.pub2
   Kai M, 2018, J MINIM INVAS GYN, V25, P447, DOI 10.1016/j.jmig.2017.09.023
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Lee Ko-Chao, 2015, Hepatogastroenterology, V62, P811
   Li J, 2017, MAT SCI ENG C-MATER, V78, P988, DOI 10.1016/j.msec.2017.04.017
   Lin LX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172088
   Malavasi L M, 2017, ANESTESIOLOGIA ANALG, P923
   Newman ME, 2018, J SURG RES, V222, P132, DOI 10.1016/j.jss.2017.09.042
   Pfeifer S, 2013, FERTIL STERIL, V99, P1550, DOI 10.1016/j.fertnstert.2013.02.031
   Stricker-Krongrad A, 2016, TOXICOL PATHOL, V44, P612, DOI 10.1177/0192623316641784
   Tabibian N, 2017, ANN MED SURG, V15, P9, DOI 10.1016/j.amsu.2017.01.021
   Torres K, 2018, ADV MED SCI-POLAND, V63, P220, DOI 10.1016/j.advms.2017.11.006
   Trochsler M, 2014, LANCET, V383, P8, DOI 10.1016/S0140-6736(13)62002-4
NR 29
TC 1
Z9 1
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 9
PY 2020
VL 15
IS 1
AR e0219105
DI 10.1371/journal.pone.0219105
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5ER
UT WOS:000534341100002
PM 31918436
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pereira, JP
   Maykin, MM
   Vasconcelos, Z
   Avvad-Portari, E
   Zin, AA
   Tsui, I
   Brasil, P
   Nielsen-Saines, K
   Moreira, ME
   Gaw, SL
AF Pereira, Jose Paulo, Jr.
   Maykin, Melanie M.
   Vasconcelos, Zilton
   Avvad-Portari, Elyzabeth
   Zin, Andrea A.
   Tsui, Irena
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria E.
   Gaw, Stephanie L.
TI The Role of Amniocentesis in the Diagnosis of Congenital Zika Syndrome
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE ZIKV; TORCH infection; perinatal infection; pregnancy; vertical
   transmission
ID VIRUS-INFECTION; PREGNANCY; FETUSES; BLOOD
AB There are limited data on amniocentesis as a diagnostic tool for congenital Zika syndrome. Here we report on a prospective cohort of 16 women with suspected Zika virus infection in a highly endemic area, and discuss the role of amniocentesis in the prenatal diagnosis of fetal Zika infection.
C1 [Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Avvad-Portari, Elyzabeth; Zin, Andrea A.; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556,HSE16, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Gaw,
   Stephanie/0000-0003-0891-6964
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K12 HD000849,
   R21AI28697, R21AI129534, R21EY028318]; Queenan Fellowship for Global
   Health; Conselho Nacional de Pesquisa-Brazilian National Research
   Council of the Brazilian Ministry of Health (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Apoio a
   Pesquisa do Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); European Union
   European Horizon 2020 Research and Innovation Programme (Zika-PLAN)
   [734584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &
   HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, K08AI141728, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, K08AI141728, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697] Funding Source: NIH
   RePORTER
FX This work was supported by the National Institutes of Health (grant
   numbers K12 HD000849 to S.L.G., R21AI28697, R21AI129534, and
   R21EY028318), the Queenan Fellowship for Global Health (to S. L. G.),
   the Conselho Nacional de Pesquisa-Brazilian National Research Council of
   the Brazilian Ministry of Health (CNPq, to M. E. M.); Fundacao de Apoio
   a Pesquisa do Rio de Janeiro (Faperj, to M. E. M); and the European
   Union European Horizon 2020 Research and Innovation Programme (Zika-PLAN
   grant number 734584).
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Besnard M, 2016, EUROSURVEILLANCE, V21, P302
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Herrera K, CASE REP PERINATAL M, V5, P374
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
NR 12
TC 4
Z9 4
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2019
VL 69
IS 4
BP 713
EP 716
DI 10.1093/cid/ciz013
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IW7LJ
UT WOS:000485171100021
PM 30624579
OA Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Rabelo, K
   de Souza, LJ
   Salomao, NG
   Machado, LN
   Pereira, PG
   Portari, EA
   Basilio-de-Oliveira, R
   de Carvalho, JJ
   Paes, MV
AF Rabelo, Kissila
   de Souza, Luiz Jose
   Salomao, Natalia Gedeao
   Machado, Lara Nascentes
   Pereira, Priscila Gomes
   Portari, Elyzabeth Avvad
   Basilio-de-Oliveira, Rodrigo
   de Carvalho, Jorge Jose
   Paes, Marciano Viana
TI ZIKA VIRUS AND PLACENTA: HISTOPATHOLOGICAL INVESTIGATION, INFLAMMATORY
   PROFILE AND ULTRASTRUCTURAL ANALYSIS IN GESTATIONS RESULTING IN CASES OF
   MICROCEPHALY OR NOT
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Rabelo, Kissila; Pereira, Priscila Gomes; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza, Luiz Jose; Machado, Lara Nascentes] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [Salomao, Natalia Gedeao; Paes, Marciano Viana] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] Inst Fernandes Figueira Fiocruz, Anat Patol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Rodrigo] Univ Fed Estado Rio de Janeiro, Anat Patol, Rio De Janeiro, Brazil.
OI Paes, Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788;
   Carvalho, Jorge/0000-0002-9426-6381
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.77
BP E41
EP E41
DI 10.1016/j.placenta.2019.06.134
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500133
DA 2020-12-01
ER

PT J
AU Salomao, N
   Souza, LJ
   Rabelo, K
   Lima, M
   Nunes, P
   Sales, AP
   Portari, E
   dos Santos, F
   Paes, M
AF Salomao, Natalia
   Souza, Luiz Jose
   Rabelo, Kissila
   Lima, Monique
   Nunes, Priscila
   Sales, Anna Paula
   Portari, Elyzabeth
   dos Santos, Flavia
   Paes, Marciano
TI PLACENTAL INJURY OF A PREGNANT WOMAN INFECTED WITH CHIKUNGUNYA IN THE
   THIRD TRIMESTER OF GESTATION
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Salomao, Natalia; Lima, Monique; Nunes, Priscila; dos Santos, Flavia; Paes, Marciano] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Souza, Luiz Jose; Sales, Anna Paula] Hosp Plantadores Cana CRDI, Campos Dos Goytacazes, Brazil.
   [Rabelo, Kissila] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
OI Paes, Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P2.74
BP E90
EP E90
DI 10.1016/j.placenta.2019.06.286
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500284
DA 2020-12-01
ER

PT J
AU Moreira, MEL
   Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Damasceno, L
   Pone, M
   Carvalho, LMA
   Pone, SM
   Vasconcelos, Z
   Ribeiro, IP
   Zin, AA
   Tsui, I
   Adachi, K
   Gaw, SL
   Halai, UA
   Salles, TS
   da Cunha, DC
   Bonaldo, MC
   Gabaglia, CR
   Guida, L
   Malacarne, J
   Costa, RP
   Gomes, SC
   Reis, AB
   Soares, FVM
   Hasue, RH
   Aizawa, CYP
   Genovesi, FF
   Aibe, M
   Einspieler, C
   Marschik, PB
   Pereira, JP
   Portari, EA
   Janzen, C
   Cherry, JD
AF Elisabeth Lopes Moreira, M.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Damasceno, Luana
   Pone, Marcos
   Carvalho, Liege M. A.
   Pone, Sheila M.
   Vasconcelos, Zilton
   Ribeiro, Ieda P.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Gaw, Stephanie L.
   Halai, Umme-Aiman
   Salles, Tania S.
   da Cunha, Denise C.
   Bonaldo, Myrna C.
   Gabaglia, Claudia Raja
   Guida, Leticia
   Malacarne, Jociele
   Costa, Roozemerie P.
   Clair Gomes, S., Jr.
   Beatriz Reis, A.
   Soares, Fernanda V. M.
   Hasue, Renata H.
   Aizawa, Carolina Y. P.
   Genovesi, Fernanda F.
   Aibe, Mitsue
   Einspieler, Christa
   Marschik, Peter B.
   Paulo Pereira, J., Jr.
   Portari, Elyzabeth A.
   Janzen, Carla
   Cherry, James D.
TI Neurodevelopment in Infants Exposed to Zika Virus In Utero
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Elisabeth Lopes Moreira, M.; Brasil, Patricia; Damasceno, Luana; Pone, Marcos; Carvalho, Liege M. A.; Pone, Sheila M.; Vasconcelos, Zilton; Ribeiro, Ieda P.; Zin, Andrea A.; Salles, Tania S.; da Cunha, Denise C.; Bonaldo, Myrna C.; Guida, Leticia; Malacarne, Jociele; Costa, Roozemerie P.; Clair Gomes, S., Jr.; Beatriz Reis, A.; Soares, Fernanda V. M.; Aibe, Mitsue; Paulo Pereira, J., Jr.; Portari, Elyzabeth A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin; Tsui, Irena; Adachi, Kristina; Halai, Umme-Aiman; Janzen, Carla] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, Renata H.; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria.
RP Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Hasue, Renata Hydee/B-2328-2013; da Silva Pone, Marcos
   Vinicius/N-1285-2019; Junior, Clair Gomes/F-7579-2012; Vasconcelos,
   Zilton/AAD-5784-2019; Marschik, Peter B/F-8195-2011
OI Junior, Clair Gomes/0000-0002-1554-943X; Vasconcelos,
   Zilton/0000-0002-2193-2224; Reis, AlessanRSS/0000-0001-8486-7469;
   Ribeiro, Ivonizete Pires/0000-0003-0737-5430; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915;
   Marschik, Peter B/0000-0001-8932-0980
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil [25000.072811/2016-17]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [88887.116627/2016-01]; Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015TXB]; ZIKAlliance; Thrasher Research Fund [20164370]; National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [AI129847-01]; Wellcome TrustWellcome Trust; United
   Kingdom Department for International Development [205377-Z16-Z];
   European Union Horizon 2020 research and innovation program (ZikaPLAN)
   [734584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &
   HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849, K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318, R21EY028318] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P30AI028697, R01AI140718, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, R01AI140718, P30AI028697, P30AI028697,
   P30AI028697, R01AI140718, P30AI028697, P30AI028697, P30AI028697] Funding
   Source: NIH RePORTER
FX Supported by grants from the Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil (25000.072811/2016-17);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   (88887.116627/2016-01); Brazilian National Council for Scientific and
   Technological Development (CNPq) (441098/2016-9); Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   (E_18/2015TXB); ZIKAlliance; the Thrasher Research Fund (20164370); the
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH) (AI28697 and AI1259534-01); the National Eye
   Institute of the NIH (AI129847-01); the Wellcome Trust and the United
   Kingdom Department for International Development (205377-Z16-Z); and the
   European Union Horizon 2020 research and innovation program (ZikaPLAN
   grant agreement no. 734584).
CR Bayley N., 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 5
TC 21
Z9 21
U1 1
U2 10
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 13
PY 2018
VL 379
IS 24
BP 2377
EP 2379
DI 10.1056/NEJMc1800098
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA HD9HM
UT WOS:000452872600015
PM 30575464
OA Bronze, Green Accepted
DA 2020-12-01
ER

PT J
AU Pereira, WS
   da Silva, GP
   Vigliano, MV
   Leal, NRF
   Pinto, FA
   Fernandes, DC
   Santos, SVM
   Martino, T
   Nascimento, JR
   de Azevedo, APS
   Fonseca, EN
   Velozo, LSM
   Neto, LRS
   Bastos, FF
   Portari, EA
   Sabino, KCC
   Nascimento, F
   Coelho, MGP
AF Pereira, Wanderson S.
   da Silva, Girlaine P.
   Vigliano, Mariana V.
   Leal, Nathalia R. F.
   Pinto, Fabiana A.
   Fernandes, Daniele C.
   Santos, Shirley V. M.
   Martino, Thiago
   Nascimento, Johnny R.
   de Azevedo, Ana Paula S.
   Fonseca, Eduardo N.
   Velozo, Leosvaldo S. M.
   Souza Neto, Lauro R.
   Bastos, Frederico F.
   Portari, Elyzabeth A.
   Carvalho Sabino, Katia C.
   Nascimento, Flavia
   Coelho, Marsen G. P.
TI Anti-arthritic properties of crude extract from Chenopodium ambrosioides
   L. leaves
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
DE arthritis; Chenopodium ambrosioides; cytokines; inflammation
ID COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; ANTIFUNGAL ACTIVITY;
   ESSENTIAL OIL; QUERCETIN; CYTOKINES; MICE; METHOTREXATE; INFLAMMATION;
   INHIBITION
AB ObjectivesTo evaluate the effect of hydroalcoholic crude extract (HCE) from Chenopodium ambrosioides leaves on the development of type II collagen-induced arthritis (CIA) and on pro-inflammatory cytokine balance.
   MethodsCollagen-induced arthritis was induced in DBA1/J mice. On the 21st day, the mice were treated orally with HCE or methotrexate, daily. Six weeks after beginning the treatment, the following measures were determined: lymphoid organs cell numbers, percentage of blood cells, IL-6, IFN-, TNF- and IL-17 serum concentrations, activity of hepatic and kidney glutathione S-transferase, hepatic 7-ethoxyresorufin-O-deethylase activity, bone density and histopathology.
   Key findingsTreatment of CIA mice with HCE 5mg/kg (HCE5) reduced the percentage of neutrophils and macrophages and the number of bone marrow cells and increased the lymphocyte numbers and the inguinal lymph node cellularity. This treatment inhibited the serum concentration of IL-6 and TNF-, which may be related to the preservation of bone density and to the slight thickening of periarticular tissues, with minimal fibrosis and fibroblast proliferation in the joints. The CIA group presented advanced articular erosion and synovial hyperplasia. Phytochemical analysis showed mainly flavonols.
   ConclusionsHCE5 presented anti-arthritic potential and reduced IL-6 and TNF-, which participate directly in the development and maintenance of the inflammatory process in rheumatoid arthritis.
C1 [Pereira, Wanderson S.; da Silva, Girlaine P.; Vigliano, Mariana V.; Leal, Nathalia R. F.; Pinto, Fabiana A.; Fernandes, Daniele C.; Santos, Shirley V. M.; Martino, Thiago; Velozo, Leosvaldo S. M.; Carvalho Sabino, Katia C.; Coelho, Marsen G. P.] Univ Estado Rio De Janeiro, Lab Appl Immunol & Biochem Prot & Nat Prod, Dept Biochem, Biomed Ctr,Inst Biol Roberto Alcantara Gomes, Rio De Janeiro, RJ, Brazil.
   [Pereira, Wanderson S.; Nascimento, Johnny R.; de Azevedo, Ana Paula S.; Nascimento, Flavia] Univ Fed Maranhao, Lab Immunophysiol, Dept Pathol, Ctr Biol Sci & Hlth, Sao Luis, Maranhao, Brazil.
   [Fonseca, Eduardo N.] Univ Estado Rio De Janeiro, Dept Plant Biol, Inst Biol Roberto Alcantara Gomes, Biomed Ctr, Rio De Janeiro, RJ, Brazil.
   [Souza Neto, Lauro R.; Bastos, Frederico F.] Univ Estado Rio De Janeiro, Lab Biochem Toxicol, Dept Biochem, Biomed Ctr, Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth A.] Univ Estado Rio De Janeiro, Dept Pathol & Labs, Pathol Anat, Biomed Ctr, Rio De Janeiro, RJ, Brazil.
RP Coelho, MGP (corresponding author), Univ Estado Rio de Janeiro, Inst Biol, Dept Bioquim, Ctr Biomed, Ave Prof Manoel de Abreu 444,4 Andar, BR-20550170 Rio De Janeiro, RJ, Brazil.
EM marsengpc@yahoo.com.br
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPEMA; CAPESCAPES; CNPqNational Council for
   Scientific and Technological Development (CNPq); UERJ
FX We thank the personnel of LIA-BPPN for their technical assistance. This
   study was supported by FAPERJ, FAPEMA, CAPES, CNPq and UERJ.
CR Barros L, 2013, J FUNCT FOODS, V5, P1732, DOI 10.1016/j.jff.2013.07.019
   Calado GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141886
   Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736
   Chabaud M, 2001, J IMMUNOL, V167, P6015, DOI 10.4049/jimmunol.167.10.6015
   Chiarello B, 2005, FISIOTERAPIA REUMATO
   Chirumbolo Salvatore, 2010, Inflammation & Allergy Drug Targets, V9, P263
   Costa GM, 2011, J BRAZIL CHEM SOC, V22, P1096, DOI 10.1590/S0103-50532011000600014
   Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3
   Cruz GVB, 2007, J ETHNOPHARMACOL, V111, P148, DOI 10.1016/j.jep.2006.11.006
   D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018
   Filippin Lidiane Isabel, 2008, Rev. Bras. Reumatol., V48, P17, DOI 10.1590/S0482-50042008000100005
   Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33
   Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593
   Gardi C, 2015, ARCH BIOCHEM BIOPHYS, V583, P150, DOI 10.1016/j.abb.2015.08.008
   Garnero P, 2010, ARTHRITIS RHEUM-US, V62, P33, DOI 10.1002/art.25053
   Guglani L, 2010, CURR OPIN HIV AIDS, V5, P120, DOI 10.1097/COH.0b013e328335c2f6
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Haleagrahara N, 2017, BIOMED PHARMACOTHER, V90, P38, DOI 10.1016/j.biopha.2017.03.026
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   Hoes JN, 2010, NAT REV RHEUMATOL, V6, P693, DOI 10.1038/nrrheum.2010.179
   Corbacho MI, 2010, REV BRAS REUMATOL, V50, P37, DOI 10.1590/S0482-50042010000100004
   JAIN N, 1990, PHYTOCHEMISTRY, V29, P3988, DOI 10.1016/0031-9422(90)85389-W
   Jardim CM, 2010, J BRAZIL CHEM SOC, V21, P1814, DOI 10.1590/S0103-50532010001000004
   Jardim CM, 2008, J CHEM ECOL, V34, P1213, DOI 10.1007/s10886-008-9526-z
   Klassen CD, 1996, CASARETT DOULLS TOXI
   Komatsu N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00077
   Kumar R, 2007, INT J FOOD MICROBIOL, V115, P159, DOI 10.1016/j.ijfoodmicro.2006.10.017
   Lall N, 1999, J ETHNOPHARMACOL, V66, P347, DOI 10.1016/S0378-8741(98)00185-8
   Lee WS, 2014, INFLAMMATION, V37, P1221, DOI 10.1007/s10753-014-9849-6
   Lima OC, 1999, BRAZ J MED BIOL RES, V32, P651, DOI 10.1590/S0100-879X1999000500020
   Louzada-Junior Paulo, 2007, Rev. Bras. Reumatol., V47, P84, DOI 10.1590/S0482-50042007000200002
   Mateen S, 2016, CLIN CHIM ACTA, V455, P161, DOI 10.1016/j.cca.2016.02.010
   Monzote L, 2007, BIOMED PHARMACOTHER, V61, P148, DOI 10.1016/j.biopha.2006.12.001
   Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065
   Nascimento FRF, 2006, LIFE SCI, V78, P2650, DOI 10.1016/j.lfs.2005.10.006
   Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320
   Okamoto T, 2003, J RHEUMATOL, V30, P1157
   Okamoto T, 2005, OXIDAT STRESS DIS, V18, P245
   Ozkan Y, 2007, CLIN RHEUMATOL, V26, P64, DOI 10.1007/s10067-006-0244-z
   Pan DM, 2018, INT IMMUNOPHARMACOL, V55, P174, DOI 10.1016/j.intimp.2017.12.011
   Pereira WS, 2010, J ETHNOPHARMACOL, V127, P602, DOI 10.1016/j.jep.2009.12.018
   Perez-Cano FJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100659
   PETERSON GL, 1983, METHOD ENZYMOL, V91, P95
   Pisetsky DS, 2012, BEST PRACT RES CL RH, V26, P251, DOI 10.1016/j.berh.2012.03.001
   Pollinger B, 2012, J MOL MED BERL, V90, P1432
   Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392
   Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721
   Sabino KCC, 1999, PHYTOTHER RES, V13, P613, DOI 10.1002/(SICI)1099-1573(199911)13:7&lt;613::AID-PTR503&gt;3.0.CO;2-D
   Santoni FC, 2007, FISIOTER MOV, V20, P101
   Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4
   SENNA L., 2015, LISTA ESPECIES FLORA
   Senna TR, 2004, J RHEUMATOL, V31, P594
   Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117
   Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3
   Soares CD, 2015, ACTA CIR BRAS, V30, P812, DOI 10.1590/S0102-865020150120000004
   Sousa ZL, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-20
   Sung JY, 2000, IMMUNOPHARMACOLOGY, V47, P35, DOI 10.1016/S0162-3109(99)00185-X
   Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]
   TrivellatoGrassi L, 2013, J ETHNOPHARMACOL, V145, P127, DOI 10.1016/j.jep.2012.10.040
   Venkatesha SH, 2015, INT J MOL SCI, V16, P887, DOI 10.3390/ijms16010887
   Wright AT, 2009, J AM CHEM SOC, V131, P10692, DOI 10.1021/ja9037609
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 62
TC 1
Z9 1
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD AUG
PY 2018
VL 70
IS 8
BP 1078
EP 1091
DI 10.1111/jphp.12926
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GM0LK
UT WOS:000437741300011
PM 29708588
DA 2020-12-01
ER

PT J
AU Chimelli, L
   Pone, SM
   Avvad-Portari, E
   Vasconcelos, ZFM
   Zin, AA
   Cunha, DP
   Thompson, NR
   Moreira, MEL
   Wiley, CA
   Pone, MVD
AF Chimelli, Leila
   Pone, Sheila Moura
   Avvad-Portari, Elyzabeth
   Meira Vasconcelos, Zilton Farias
   Zin, Andrea Araujo
   Cunha, Daniela Prado
   Thompson, Nathalia Raposo
   Lopes Moreira, Maria Elisabeth
   Wiley, Clayton A.
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth: Clinical, Virological,
   Neuroimaging, and Neuropathological Documentation in a 5-Month Infant
   With Congenital Zika Syndrome
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Arthrogryposis; Calcification; Hydrocephalus; Microcephaly;
   Neuropathology; RT-qPCR; Zika virus
ID INFECTION; POSTMORTEM; BRAIN
AB During the Zika epidemic in Brazil, a baby was born at term with microcephaly and arthrogryposis. The mother had Zika symptoms at 10 weeks of gestation. At 17 weeks, ultrasound showed cerebral malformation and ventriculomegaly. At 24 weeks, the amniotic fluid contained ZIKV RNA and at birth, placenta and maternal blood were also positive using RT-qPCR. At birth the baby urine contained ZIKV RNA, whereas CSF at birth and urine at 17 days did not. Seizures started at 6 days. EEG was abnormal and CT scan showed cerebral atrophy, calcifications, lissencephaly, ventriculomegaly, and cerebellar hypoplasia. Bacterial sepsis at 2 months was treated. A sudden increase in head circumference occurred at 4 months necessitating ventricle-peritoneal shunt placement. At 5 months, the infant died with sepsis due to bacterial meningitis. Neuropathological findings were as severe as some of those found in neonates who died soon after birth, including hydrocephalus, destructive lesions/calcification, gliosis, abnormal neuronal migration, dysmaturation of nerve cells, hypomyelination, loss of descending axons, and spinal motor neurons. ZIKV RNA was detected only in frozen brain tissue using RT-qPCR, but infected cells were not detected by in situ hybridization. Progressive gliosis and microgliosis in the midbrain may have contributed to aqueduct compression and subsequent hydrocephalus. The etiology of progressive disease after in utero infection is not clear and requires investigation.
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Pone, Sheila Moura; Thompson, Nathalia Raposo; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pediat Infect Dis, Rio De Janeiro, Brazil.
   [Avvad-Portari, Elyzabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pathol, Rio De Janeiro, Brazil.
   [Meira Vasconcelos, Zilton Farias; Zin, Andrea Araujo; Cunha, Daniela Prado; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Rio De Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Vasconcelos, Zilton/AAD-5784-2019; da Silva Pone, Marcos
   Vinicius/N-1285-2019; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Cunha, Daniela/0000-0002-5954-6054; Moura
   Pone, Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Ochieng' N, 2015, J NEUROSURG-PEDIATR, V15, P150, DOI 10.3171/2014.10.PEDS14178
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Siebert JR, 2007, POTTERS PATHOLOGY FE, P695
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 16
TC 18
Z9 18
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAR
PY 2018
VL 77
IS 3
BP 193
EP 198
DI 10.1093/jnen/nlx116
PG 6
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GB3IH
UT WOS:000428949800002
PM 29346650
DA 2020-12-01
ER

PT J
AU Chimelli, L
   Avvad-Portari, E
AF Chimelli, L.
   Avvad-Portari, E.
TI Congenital Zika virus infection: a neuropathological review
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Congenital Zika virus infection; Neuropathology; Microcephaly;
   Ventriculomegaly; Calcifications; Migration disturbances
AB Background A relationship between Zika virus (ZikV) infection in pregnancy and the occurrence of microcephaly was established during the Zika outbreak in Brazil (2015-2016). Neuropathological findings in congenital Zika syndrome helped to understand its pathogenetic mechanisms. Results The most relevant postmortem findings in the central nervous system (CNS) of fetuses and neonates infected with ZikV early in gestation are microcephaly with ex-vacuo ventriculomegaly and large head circumference associated with obstructive hydrocephalus due to severe midbrain and aqueduct distortion. Babies with severe brain lesions are born with arthrogryposis. Histologically, there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia and occasional perivascular cuffs of lymphocytes, also in the meninges. Hypoplastic lesions secondary to the lack of descending nerve fibers include small basis pontis, pyramids and spinal corticospinal tracts. Cerebellar hypoplasia is also common. Severe nerve motor nerve cell loss is observed in the anterior horn of the spinal cord. Conclusion A spectrum of neuropathological changes, from severe microcephaly to obstructive hydrocephalus was observed. The severity of the lesions is directly related to the gestational age, the most severe occurring when the mother is infected in the first trimester. Infection of progenitor cells at the germinal matrix was demonstrated. The lack of spinal motor neurons is responsible for fetal acynesia and consequent arthrogryposis.
C1 [Chimelli, L.] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [Chimelli, L.] Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
   [Avvad-Portari, E.] Oswaldo Cruz Fdn Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Avvad-Portari, E.] State Univ Rio De Janeiro UERJ, Rio De Janeiro, Brazil.
RP Avvad-Portari, E (corresponding author), Oswaldo Cruz Fdn Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Avvad-Portari, E (corresponding author), State Univ Rio De Janeiro UERJ, Rio De Janeiro, Brazil.
EM bethavvad@gmail.com
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 9
TC 12
Z9 13
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 95
EP 99
DI 10.1007/s00381-017-3651-3
PG 5
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300018
PM 29167994
DA 2020-12-01
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Amorim, Melania M/C-5807-2013; Ferreira,
   Thales Araujo/AAA-6252-2019; Moll, Fernanda Tovar/N-3320-2018; Melo,
   Adriana S O/H-5650-2016; Rehen, Stevens K/J-5874-2012; ANDRADE,
   CECILIA/B-5916-2017
OI Aguiar, Renato S/0000-0001-5180-3717; Amorim, Melania
   M/0000-0003-1047-2514; Moll, Fernanda Tovar/0000-0002-0292-5985; Rehen,
   Stevens K/0000-0003-4216-9501; FERREIRA, THALES/0000-0002-6699-5886;
   Soares de Oliveira Szejnfeld, Patricia/0000-0002-3780-5182; ANDRADE,
   CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15102] Funding Source: researchfish; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI111598,
   U01AI111598, U01AI111598, U01AI111598, U01AI111598, U01AI111598] Funding
   Source: NIH RePORTER
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 73
Z9 76
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-12-01
ER

PT J
AU Racca, AC
   Ridano, ME
   Bandeira, CL
   Bevilacqua, E
   Portari, EA
   Genti-Raimondi, S
   Graham, CH
   Panzetta-Dutari, GM
AF Racca, A. C.
   Ridano, M. E.
   Bandeira, C. L.
   Bevilacqua, E.
   Avvad Portari, E.
   Genti-Raimondi, S.
   Graham, C. H.
   Panzetta-Dutari, G. M.
TI Low oxygen tension induces Kruppel-Like Factor 6 expression in
   trophoblast cells
SO PLACENTA
LA English
DT Article
DE Hypoxia; Kruppel-Like Factor 6; Hypoxia inducible factor-1 alpha;
   Placenta; Trophoblast
ID TRANSCRIPTION FACTOR KLF6; HYPOXIA-INDUCIBLE FACTORS; OXIDATIVE STRESS;
   PLACENTA; ENDOGLIN; PROLIFERATION; ONCOPROTEIN; ACTIVATION; REGULATOR;
   PROMOTE
AB The transcription factor Kruppel-Like Factor 6 (KLF6) has important roles in cell differentiation, angiogenesis, apoptosis, and proliferation. Furthermore, there is evidence that KLF6 is required for proper placental development. While oxygen is a critical mediator of trophoblast differentiation and function, the involvement of oxygen in the regulation of KLF6 expression remains unexplored. In the present study we examined the expression of KLF6 in placental tissue from uncomplicated and preeclamptic pregnancies, the latter often characterized by an inadequately perfused placenta. We also determined the effect of hypoxia and the involvement of Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) on the expression of KLF6 in cultured trophoblast cells and placental tissues. Results revealed that villous, interstitial and endovascular extravillous cytotrophoblasts from placentas from normal and preeclamptic pregnancies express KLF6. In addition, KLF6 immunoreactivity was higher in the placental bed of preeclamptic pregnancies than in those of uncomplicated pregnancies. We demonstrated that hypoxia induced an early and transient increase in KLF6 protein levels in HTR8/SVneo extravillous cytotrophoblast cells and in placental explants. Reoxygenation returned KLF6 protein to basal levels. Moreover, hypoxia-induced up regulation of KLF6 expression was dependent on HIF-1 alpha as revealed by siRNA knockdown in HTR8/SVneo cells. These results indicate that KLF6 may mediate some of the effects of hypoxia in placental development. The regulation of KLF6 protein levels by oxygen has significant implications for understanding its putative role in diseases affected by tissue hypoxia. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Racca, A. C.; Ridano, M. E.; Genti-Raimondi, S.; Panzetta-Dutari, G. M.] Univ Nacl Cordoba, CONICET, Ctr Invest Bioquim Clin & Inmunol CIBICI, Dept Bioquim Clin,Fac Ciencias Quim, Cordoba, Argentina.
   [Bandeira, C. L.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
   [Avvad Portari, E.] Univ Estado Rio De Janeiro, Sch Med Sci, Dept Pathol, Rio De Janeiro, Brazil.
   [Graham, C. H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Graham, C. H.] Queens Univ, Dept Urol, Kingston, ON, Canada.
RP Panzetta-Dutari, GM (corresponding author), Univ Nacl Cordoba, CONICET, CIBICI, Dept Bioquim Clin,Fac Ciencias Quim, Ciudad Univ,X5000HUA, Cordoba, Argentina.
EM gpan@fcq.unc.edu.ar
RI Bandeira, Carla Leticia/U-8685-2017; Bevilacqua, Estela/H-3354-2011
OI Bandeira, Carla Leticia/0000-0002-0796-3462; Bevilacqua,
   Estela/0000-0003-4178-4625; Racca, Ana Cristina/0000-0002-5909-2451
FU Consejo Nacional de Investigaciones Cientificas y Tecnologicas de
   Argentina (CONICET)Consejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET); Agencia Nacional de Promocion Ciencia y Tecnica
   (FONCYT) PICT [2011-0452, 2014-0806]; Secretaria de Ciencia y Tecnica de
   la Universidad Nacional de Cordoba (SECyT-UNC)Secretaria de Ciencia y
   Tecnologia (SECYT); Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR) [MOP 119496]; CONICETConsejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET);
   International Union of Biochemistry and Molecular Biology
FX We gratefully acknowledge Drs. Gustavo Chiabrando and Jose Luis Bocco
   for reagents and helpful advice. This work was supported by the Consejo
   Nacional de Investigaciones Cientificas y Tecnologicas de Argentina
   (CONICET), the Agencia Nacional de Promocion Ciencia y Tecnica (FONCYT)
   PICT 2011-0452 and 2014-0806, and the Secretaria de Ciencia y Tecnica de
   la Universidad Nacional de Cordoba (SECyT-UNC), as well as the Canadian
   Institutes of Health Research (grant number MOP 119496, awarded to CHG).
   G.M.P-D. and S.G-R. are Career Investigators of CONICET. A.C.R and M.E.R
   thank CONICET for their fellowship. A.C.R acknowledges the Journal of
   Cell Science and the Wood-Whelan Research Fellowship from the
   International Union of Biochemistry and Molecular Biology, for her
   Travelling Fellowships.
CR Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033
   Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396
   Bandeira CL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/892856
   Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4
   Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001
   Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb
   Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102
   Chen PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071282
   Racca AC, 2015, MOL HUM REPROD, V21, P347, DOI 10.1093/molehr/gau113
   Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007
   Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001
   Dionyssiou MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-7
   ElRouby S, 1996, ONCOGENE, V13, P2623
   Erol AYG, 2012, ENDOCRINE, V42, P125, DOI 10.1007/s12020-012-9644-9
   Fulda Simone, 2010, Int J Cell Biol, V2010, P214074, DOI 10.1155/2010/214074
   Gallardo-Vara E, 2016, ANGIOGENESIS, V19, P155, DOI 10.1007/s10456-016-9495-8
   Garrido-Martin EM, 2013, CIRC RES, V112, P113, DOI 10.1161/CIRCRESAHA.112.275586
   Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139
   Gregory AL, 2014, PLACENTA, V35, pS93, DOI 10.1016/j.placenta.2013.10.020
   Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189
   Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3
   Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008
   Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029
   Kim Y., J BIOL CHEM, V273
   Knofler M, 2012, PLACENTA, V33, pS55, DOI 10.1016/j.placenta.2011.09.019
   Koizume S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0351-z
   Koritschoner NP, 1997, J BIOL CHEM, V272, P9573
   Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012
   Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022
   Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620
   Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916
   McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009
   Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799
   Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516
   Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046
   Racca AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022438
   Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500
   Slavin D, 1999, BIOL REPROD, V61, P1586, DOI 10.1095/biolreprod61.6.1586
   Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020
   Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723
   Tarabishi R, 2005, KIDNEY INT, V68, P1511, DOI 10.1111/j.1523-1755.2005.00563.x
   Zhao XA, 2010, DEV BIOL, V344, P79, DOI 10.1016/j.ydbio.2010.04.018
NR 44
TC 2
Z9 3
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2016
VL 45
BP 50
EP 57
DI 10.1016/j.placenta.2016.07.006
PG 8
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DV9WX
UT WOS:000383294000008
PM 27577710
DA 2020-12-01
ER

PT J
AU Vargas-Torres, SL
   Portari, EA
   Silva, AL
   Klumb, EM
   Guillobel, HCD
   de Camargo, MJ
   Santos-Reboucas, CB
   Russomano, FB
   Macedo, JMB
AF Vargas-Torres, Sandra Liliana
   Portari, Elyzabeth Avvad
   Silva, Amanda Lima
   Klumb, Evandro Mendes
   da Rocha Guillobel, Heloisa Carneiro
   de Camargo, Maria Jose
   Santos-Reboucas, Cintia Barros
   Russomano, Fabio Bastos
   Brito Macedo, Jacyara Maria
TI Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the
   development of cervical neoplasia
SO TUMOR BIOLOGY
LA English
DT Article
DE CDKN1A; Cervical neoplasia; rs1801270; rs1059234; p21; Polymorphism
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; DEPENDENT KINASE INHIBITOR;
   SQUAMOUS-CELL CARCINOMA; CODON 31 POLYMORPHISM; CHINESE WOMEN; P21 GENE;
   CANCER SUSCEPTIBILITY; BRAZILIAN POPULATION; KOREAN WOMEN; CYCLIN D1
AB The CDKN1A gene product is a p53 downstream effector, which participates in cell differentiation, development process, repair, apoptosis, senescence, migration, and tumorigenesis. The objective of our study was investigated the importance of two polymorphisms in the CDKN1A gene, rs1801270 (31C > A) and rs1059234 (70C > T), for the development of cervical lesions in a Southeastern Brazilian population (283 cases, stratified by lesion severity, and 189 controls). CDKN1A genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and/or DNA sequencing. CDKN1A 31A allele presents a genetic pattern of protection for the development of high-grade cervical lesions (CC vs CA genotype: OR = 0.60; 95 % CI = 0.38-0.95; p = 0.029; CA+AA vs CC genotype: OR = 0.60; 95 % CI = 0.39-0.93; p = 0.021). Allele distributions of the CDKN1A 70C > T polymorphism were also different between the two study groups, with the CDKN1A 70T allele being less prevalent among cases. Moreover, the double heterozygote genotype combination 31CA-70CT decreases the chance of developing high-grade squamous intraepithelial lesion (HSIL) and cancer (OR = 0.55; 95 % CI = 0.32-0.93; p = 0.034) by 50 %, representing a protective factor against the development of more severe cervical lesions.
C1 [Vargas-Torres, Sandra Liliana; Silva, Amanda Lima; Brito Macedo, Jacyara Maria] State Univ Rio de Janeiro UERJ, Inst Biol, Dept Biochem, Ave 28 Setembro,87 Fundos 4 Andar, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth Avvad] State Univ Rio de Janeiro UERJ, Dept Pathol, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] Fernandes Figueira Inst FIOCRUZ, Dept Pathol, Rio De Janeiro, Brazil.
   [Klumb, Evandro Mendes] State Univ Rio de Janeiro UERJ, Dept Rheumatol, Rio De Janeiro, RJ, Brazil.
   [da Rocha Guillobel, Heloisa Carneiro] State Univ Rio de Janeiro UERJ, Dept Biophys & Biometry, Rio De Janeiro, RJ, Brazil.
   [de Camargo, Maria Jose; Russomano, Fabio Bastos] Fernandes Figueira Inst FIOCRUZ, Dept Gynecol, Rio De Janeiro, Brazil.
   [Santos-Reboucas, Cintia Barros] State Univ Rio de Janeiro UERJ, Dept Genet, Rio De Janeiro, RJ, Brazil.
RP Macedo, JMB (corresponding author), State Univ Rio de Janeiro UERJ, Inst Biol, Dept Biochem, Ave 28 Setembro,87 Fundos 4 Andar, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM jacyara@uerj.br
OI Santos-Reboucas, Cintia/0000-0003-4729-2373; Vargas-Torres, Sandra
   Liliana/0000-0003-4019-2089
CR Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657
   Bhattacharya P, 2005, GYNECOL ONCOL, V99, P176, DOI 10.1016/j.ygyno.2005.06.007
   Birgander R, 1996, HUM HERED, V46, P148, DOI 10.1159/000154344
   Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4
   CHEDID M, 1994, ONCOGENE, V9, P3021
   Chen EY, 2010, MODERN PATHOL, V23, P1045, DOI 10.1038/modpathol.2010.85
   Coleman Natalia, 2012, Cell Logist, V2, P132
   de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Ferlay J, 2013, GLOBOCAN 2012 V1 0 C
   Gomes CC, 2008, J ORAL PATHOL MED, V37, P151, DOI 10.1111/j.1600-0714.2007.00604.x
   Harima Y, 2001, INT J MOL MED, V7, P261
   Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005
   Iniesta Raquel, 2005, Gac Sanit, V19, P333, DOI 10.1157/13078029
   Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006
   Jiang P, 2010, ACTA BIOCH BIOPH SIN, V42, P671, DOI 10.1093/abbs/gmq069
   Johnson GG, 2009, CANCER RES, V69, P5210, DOI 10.1158/0008-5472.CAN-09-0627
   Klumb EM, 2010, LUPUS, V19, P1485, DOI 10.1177/0961203310372952
   Konishi R, 2000, J DERMATOL SCI, V24, P177, DOI 10.1016/S0923-1811(00)00096-7
   Li GJ, 2005, CARCINOGENESIS, V26, P1596, DOI 10.1093/carcin/bgi105
   Liu F, 2011, MUTAGENESIS, V26, P513, DOI 10.1093/mutage/ger010
   Lukas J, 1997, AM J PATHOL, V150, P167
   Ma Hongxia, 2011, Chin J Cancer, V30, P254
   Ma YC, 2013, TUMOR BIOL, V34, P3887, DOI 10.1007/s13277-013-0976-8
   Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
   Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138
   Overton W, 2014, PNAS, pe4386
   Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6
   Roh JW, 2010, ONCOL RES, V18, P453, DOI 10.3727/096504010X12671222663719
   Roh JW, 2001, CANCER LETT, V165, P59, DOI 10.1016/S0304-3835(01)00401-3
   Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867
   Carvalho INSR, 2013, CARCINOGENESIS, V34, P2774, DOI 10.1093/carcin/bgt308
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Sousa H, 2011, ACTA MEDICA PORT, V24, P127
   Su L, 2003, LUNG CANCER-J IASLC, V40, P259, DOI 10.1016/S0169-5002(03)00081-3
   SUN Y, 1995, CANCER EPIDEM BIOMAR, V4, P261
   Taghavi N, 2010, ARCH IRAN MED, V13, P235
   Tanno B, 2005, CELL DEATH DIFFER, V12, P213, DOI 10.1038/sj.cdd.4401546
   Tian QF, 2009, INT J GYNECOL CANCER, V19, P1011, DOI 10.1111/IGC.0b013e3181a8b950
   Valentin MD, 2009, SAO PAULO MED J, V127, P288, DOI 10.1590/S1516-31802009000500008
   Vargas-Torres SL, 2014, BIOMARKERS, V19, P637, DOI 10.3109/1354750X.2014.962614
   Vargas-Torres SL, 2014, BIOMARKERS, V19, P121, DOI 10.3109/1354750X.2014.881419
   Wang N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-589
   Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62
   Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34
   Yin D, 2015, CELL BIOCHEM BIOPHYS, V71, P167, DOI 10.1007/s12013-014-0180-5
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 47
TC 7
Z9 7
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD AUG
PY 2016
VL 37
IS 8
BP 10469
EP 10478
DI 10.1007/s13277-016-4850-3
PG 10
WC Oncology
SC Oncology
GA DV1HW
UT WOS:000382672900046
PM 26846214
DA 2020-12-01
ER

PT J
AU Cunha, EF
   Martins, TM
   Canto-Cavalheiro, MM
   Marques, PR
   Portari, EA
   Coelho, MGP
   Netto, CD
   Costa, PRR
   Sabino, KCD
   Torres-Santos, EC
AF Cunha-Junior, Edezio Ferreira
   Martins, Thiago Martino
   Canto-Cavalheiro, Marilene Marcuzzo
   Marques, Paulo Roberto
   Portari, Elyzabeth Avvad
   Pinto Coelho, Marsen Garcia
   Netto, Chaquip Daher
   Ribeiro Costa, Paulo Roberto
   de Carvalho Sabino, Katia Costa
   Torres-Santos, Eduardo Caio
TI Preclinical Studies Evaluating Subacute Toxicity and Therapeutic
   Efficacy of LQB-118 in Experimental Visceral Leishmaniasis
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID MALIGNANT CELL-LINES; ANTINEOPLASIC ACTIVITY; TREATMENT FAILURE; BALB/C
   MICE; PTEROCARPANQUINONE; RESISTANCE; INFANTUM; HEXADECYLPHOSPHOCHOLINE;
   MILTEFOSINE; INFECTION
AB Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and is the second major cause of death by parasites, after malaria. The arsenal of drugs against leishmaniasis is small, and each has a disadvantage in terms of toxicity, efficacy, price, or treatment regimen. Our group has focused on studying new drug candidates as alternatives to current treatments. The pterocarpanquinone LQB-118 was designed and synthesized based on molecular hybridization, and it exhibited antiprotozoal and antileukemic cell line activities. Our previous work demonstrated that LQB-118 was an effective treatment for experimental cutaneous leishmaniasis. In this study, we observed that treatment with 10 mg/kg of body weight/day LQB-118 orally inhibited the development of hepatosplenomegaly with a 99% reduction in parasite load. An in vivo toxicological analysis showed no change in the clinical, biochemical, or hematological parameters. Histologically, all of the analyzed organs were normal, with the exception of the liver, where focal points of necrosis with leukocytic infiltration were observed at treatment doses 5 times higher than the therapeutic dose; however, these changes were not accompanied by an increase in transaminases. Our findings indicate that LQB-118 is effective at treating different clinical forms of leishmaniasis and presents no relevant signs of toxicity at therapeutic doses; thus, this framework is demonstrated suitable for developing promising drug candidates for the oral treatment of leishmaniasis.
C1 [Cunha-Junior, Edezio Ferreira; Canto-Cavalheiro, Marilene Marcuzzo; Torres-Santos, Eduardo Caio] Inst Oswaldo Cruz, Lab Bioquim Tripanosomatideos, BR-20001 Rio De Janeiro, RJ, Brazil.
   [Martins, Thiago Martino; Marques, Paulo Roberto; Pinto Coelho, Marsen Garcia; de Carvalho Sabino, Katia Costa] Univ Estado Rio de Janeiro, Lab Imunol Aplicada & Bioq Prot & Prod Nat, Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth Avvad] Univ Estado Rio de Janeiro, Dept Patol & Labs, Rio De Janeiro, RJ, Brazil.
   [Netto, Chaquip Daher] Univ Fed Rio de Janeiro, Lab Quim, Macae, RJ, Brazil.
   [Ribeiro Costa, Paulo Roberto] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat, Rio De Janeiro, RJ, Brazil.
RP Torres-Santos, EC (corresponding author), Inst Oswaldo Cruz, Lab Bioquim Tripanosomatideos, BR-20001 Rio De Janeiro, RJ, Brazil.
EM ects@ioc.fiocruz.br
RI Cunha-Junior, Edezio/F-5200-2018; Netto, Chaquip Daher/G-7467-2014;
   Torres-Santos, Eduardo Caio/J-9908-2014; Ribeiro Costa, Paulo
   Roberto/F-1153-2013
OI Cunha-Junior, Edezio/0000-0002-2833-1771; Netto, Chaquip
   Daher/0000-0001-5627-6856; Torres-Santos, Eduardo
   Caio/0000-0003-2240-4519; Ribeiro Costa, Paulo
   Roberto/0000-0001-9541-1707
FU MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [26/110.731/2012,
   26/110.613/2012, 26/110.401/2014]
FX This work, including the efforts of Paulo Roberto Ribeiro Costa and
   Eduardo Caio Torres-Santos, was funded by MCTI vertical bar Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (research
   fellows). This work, including the efforts of Paulo Roberto Ribeiro
   Costa and Eduardo Caio Torres-Santos, was funded by Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   (26/110.731/2012, 26/110.613/2012, and 26/110.401/2014).
CR ALKHAWAJAH A, 1992, HUM EXP TOXICOL, V11, P283, DOI 10.1177/096032719201100409
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Azri-Meehan S, 2013, NONCLINICAL SAFETY ASSESSMENT: A GUIDE TO INTERNATIONAL PHARMACEUTICAL REGULATIONS, P199
   Bancroft JD, 1994, MANUAL HISTOLOGICAL
   Buarque CD, 2011, BIOORGAN MED CHEM, V19, P6885, DOI 10.1016/j.bmc.2011.09.025
   BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Cojean S, 2012, EMERG INFECT DIS, V18, P704, DOI 10.3201/eid1804.110841
   Costa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109672
   da Cunha EF, 2011, J ANTIMICROB CHEMOTH, V66, P1555, DOI 10.1093/jac/dkr158
   da Silva AJM, 2009, J BRAZIL CHEM SOC, V20, P176, DOI 10.1590/S0103-50532009000100026
   De Moraes GN, 2014, INT J ONCOL, V45, P1949, DOI 10.3892/ijo.2014.2615
   den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x
   Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275
   Dwyer LA., 2000, IDEXX VETTEST CHEM A
   FDA Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, 1995, GUID IND CONT FORM I
   GOODWIN LG, 1995, T ROY SOC TROP MED H, V89, P339, DOI 10.1016/0035-9203(95)90572-3
   Greer JP, 2003, WINTROBES CLIN HEMAT, P16
   Hayes AW., 1994, PRINCIPLES METHODS T, P579
   Honore S, 1998, FEMS IMMUNOL MED MIC, V21, P231, DOI 10.1016/S0928-8244(98)00079-0
   Jain K, 2013, DRUG DISCOV TODAY, V18, P1272, DOI 10.1016/j.drudis.2013.08.005
   KUHLENCORD A, 1992, ANTIMICROB AGENTS CH, V36, P1630, DOI 10.1128/AAC.36.8.1630
   Le Fichoux Y, 1998, ANTIMICROB AGENTS CH, V42, P654, DOI 10.1128/AAC.42.3.654
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Maia RC, 2011, INVEST NEW DRUG, V29, P1143, DOI 10.1007/s10637-010-9453-z
   Murray HW, 2000, J INFECT DIS, V181, P795, DOI 10.1086/315268
   Netto CD, 2010, BIOORGAN MED CHEM, V18, P1610, DOI 10.1016/j.bmc.2009.12.073
   Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39
   Organisation for Economic Co-operation and Development, 2008, TEST 407 REP DOS 28
   Portes JD, 2012, VET PARASITOL, V186, P261, DOI 10.1016/j.vetpar.2011.11.008
   Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498
   RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0
   Rodrigues RF, 2012, J ANTIMICROB CHEMOTH, V67, P182, DOI 10.1093/jac/dkr409
   Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371
   Rolao N, 2004, ACTA TROP, V90, P123, DOI 10.1016/j.actatropica.2003.09.010
   Rousseau D, 1997, INFECT IMMUN, V65, P4978, DOI 10.1128/IAI.65.12.4978-4983.1997
   Sahasrabudhe V, 2015, J INFECT DIS, V211, pS107, DOI 10.1093/infdis/jiv009
   Sayari M, 2008, Pak J Biol Sci, V11, P1630, DOI 10.3923/pjbs.2008.1630.1633
   Shivakumar P, 2012, Toxicol Int, V19, P241, DOI 10.4103/0971-6580.103656
   Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x
   Van Kampen E J, 1965, Adv Clin Chem, V8, P141
   Vanaerschot M, 2012, J INFECT DIS, V206, P752, DOI 10.1093/infdis/jis424
   Vianna G., 1912, ARCH BRAS MED, V1, P36
NR 44
TC 10
Z9 10
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUN
PY 2016
VL 60
IS 6
BP 3794
EP 3801
DI 10.1128/AAC.01787-15
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA DN4PE
UT WOS:000377048900063
PM 27067332
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Werner, H
   Mocarzel, C
   Sa, RA
   Tonni, G
   Novoa, VANY
   Avvad-Portari, E
   Bonasoni, P
   Araujo, E
AF Werner, Heron
   Mocarzel, Carolina
   Sa, Renato Augusto
   Tonni, Gabriele
   Novoa y Novoa, Victoria Arruga
   Avvad-Portari, Elyzabeth
   Bonasoni, Paola
   Araujo Junior, Edward
TI Antenatal Diagnosis of a Large Immature Abdominal Wall Teratoma by 2D-3D
   Ultrasound Using HDlive and Magnetic Resonance Imaging
SO FETAL AND PEDIATRIC PATHOLOGY
LA English
DT Article
DE Anterior abdominal wall; prenatal diagnosis; immature teratoma;
   three-dimensional ultrasound; magnetic resonance imaging; HDlive
   rendering
ID GERM-CELL TUMORS; FETAL MEDIASTINAL TERATOMA; OF-THE-LITERATURE;
   3-DIMENSIONAL ULTRASOUND; PRENATAL-DIAGNOSIS; CERVICAL TERATOMA; MATURE
   TERATOMA; SCAN DATA; MANAGEMENT; MASS
AB We describe the first case of prenatally detected teratoma of the fetal abdomen wall using ultrasound and fetal magnetic resonance imaging (MRI). A heterogeneous mass, partly solid and cystic, originating from the anterior abdominal wall of the fetus close to an omphalocele sac was detected by means of 2D/3D ultrasound and MRI. Amniodrainage was performed and due to sign of impending fetal risk, an emergency Cesarean section was performed. A bulky, crumbly and bleeding tumoral mass was confirmed at delivery. Ligation of the supplying artery to the tumor was complicated by uncontrollable hemorrhage and early neonatal death. Pathology identified the tumor as an immature teratoma of the anterior fetal abdominal wall. 2D/3D ultrasound, especially using HDlive application and MRI demonstrated accurate detection and characterization of this congenital tumor.
C1 [Werner, Heron] CDPI, Radiol, Rio De Janeiro, Brazil.
   [Mocarzel, Carolina] Hosp Fed Servidores Estado Rio de Janeiro, Obstet, Rio De Janeiro, Brazil.
   [Sa, Renato Augusto] Clin Perinatal Laranjeiras, Obstet & Gynecol, Rio De Janeiro, Brazil.
   [Tonni, Gabriele] Guastalla Civil Hosp, Obstet & Gynecol, Reggio Emilia, Italy.
   [Novoa y Novoa, Victoria Arruga; Araujo Junior, Edward] Univ Fed Sao Paulo, Obstet, Paulista Sch Med, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, Brazil.
   [Avvad-Portari, Elyzabeth] Fundacao Oswaldo Cruz, Pathol, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Bonasoni, Paola] Arcispedale S Maria Nuova, Pathol, Reggio Emilia, Italy.
RP Araujo, E (corresponding author), Univ Fed Sao Paulo, Obstet, Paulista Sch Med, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, Brazil.
EM araujojred@terra.com.br
RI Junior, Edward Araujo/E-1228-2012; de Sa, Renato Augusto
   Moreira/B-4778-2014; Tonni, Gabriele/AAM-9842-2020; ,
   paolabonasoni/AAD-3650-2019; Werner, Heron/W-1578-2019
OI Junior, Edward Araujo/0000-0002-6145-2532; MOREIRA DE SA, RENATO
   A/0000-0001-6357-7702
CR Araujo E, 2014, J PERINAT MED, V42, P255, DOI 10.1515/jpm-2013-0141
   Asai S, 2009, FETAL DIAGN THER, V25, P76, DOI 10.1159/000201944
   Berge SJ, 2004, BRIT J ORAL MAX SURG, V42, P41, DOI 10.1016/S0266-4356(03)00174-8
   De Backer A, 2005, J PEDIATR SURG, V40, P1475, DOI 10.1016/j.jpedsurg.2005.05.048
   El-Messidi A, J OBSTET GYNAECOL CA, V31, P533
   FROBERG MK, 1994, PRENATAL DIAG, V14, P884, DOI 10.1002/pd.1970140920
   Giancotti A, 2012, CLIN EXP OBSTET GYN, V39, P384
   Goldstein I, 2005, PRENATAL DIAG, V25, P439, DOI 10.1002/pd.1056
   Gow KW, 2010, J PEDIATR SURG, V45, pE15, DOI 10.1016/j.jpedsurg.2010.07.014
   Hata T, 2012, ARCH GYNECOL OBSTET, V286, P1431, DOI 10.1007/s00404-012-2505-1
   Isaacs H, 2004, J PEDIATR SURG, V39, P1003, DOI 10.1016/j.jpedsurg.2004.03.045
   Jarrahy R, 2000, J CRANIOFAC SURG, V11, P106, DOI 10.1097/00001665-200011020-00007
   Leva E, 2012, MINERVA PEDIATR, V64, P357
   Liang HF, 2015, INT J GYNECOL OBSTET, V129, P271, DOI 10.1016/j.ijgo.2015.01.003
   Liang RI, 1998, ULTRASOUND OBST GYN, V11, P214, DOI 10.1046/j.1469-0705.1998.11030214.x
   Merchant AM, 2005, J PEDIATR SURG, V40, P228, DOI 10.1016/j.jpedsurg.2004.09.023
   Montgomery ML, 1998, ULTRASOUND OBST GYN, V11, P219, DOI 10.1046/j.1469-0705.1998.11030219.x
   REMPEN A, 1983, EUR J OBSTET GYN R B, V14, P375
   Sheil AT, 2007, AM J FOREN MED PATH, V28, P121, DOI 10.1097/01.paf.0000257373.91126.0d
   Shih HH, 1997, ULTRASOUND OBST GYN, V10, P209, DOI 10.1046/j.1469-0705.1997.10030209.x
   Tonni G, 2010, CLEFT PALATE-CRAN J, V47, P421, DOI 10.1597/08-224.1
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, J MATERN-FETAL NEO M, V29, P2229, DOI 10.3109/14767058.2015.1085015
   Werner H, 2016, CONGENIT ANOM, V56, P46, DOI 10.1111/cga.12131
   Werner H, 2015, MED ULTRASON, V17, P252, DOI 10.11152/mu.2013.2066.172.tert
NR 25
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1551-3815
EI 1551-3823
J9 FETAL PEDIATR PATHOL
JI Fetal Pediatr. Pathol.
PY 2016
VL 35
IS 6
BP 434
EP 441
DI 10.1080/15513815.2016.1214199
PG 8
WC Pathology; Pediatrics
SC Pathology; Pediatrics
GA EF2DJ
UT WOS:000390134500011
PM 27560103
DA 2020-12-01
ER

PT J
AU Vargas-Torres, SL
   Portari, EA
   Klumb, EM
   Guillobel, HCD
   de Camargo, MJ
   Russomano, FB
   Macedo, JMB
AF Vargas-Torres, Sandra Liliana
   Portari, Elyzabeth Avvad
   Klumb, Evandro Mendes
   da Rocha Guillobel, Heloisa Carneiro
   de Camargo, Maria Jose
   Russomano, Fabio Bastos
   Brito Macedo, Jacyara Maria
TI Effects of MDM2 promoter polymorphisms on the development of cervical
   neoplasia in a Southeastern Brazilian population
SO BIOMARKERS
LA English
DT Article
DE Age at onset; cervical neoplasia; genetic polymorphisms; susceptibility
ID SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION FACTOR-BINDING;
   OVARIAN-CANCER; RISK; SNP309; ASSOCIATION; P53; SNP285; SUSCEPTIBILITY;
   SEVERITY
AB We investigated the importance of two adjacent functional polymorphisms in the Murine Double Minute 2 (MDM2) gene, SNP285 G>C and SNP309 T>G, for the development of cervical lesions in a Southeastern Brazilian population (293 cases and 184 controls). MDM2 genotyping was performed by PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism) and/or DNA sequencing. MDM2 SNP309 has potential as a biomarker of cervical neoplasia in non-smokers, patients with family history of cancer, or those who had late sexual debut (>16 years). Besides, this polymorphism may help identify women at risk of developing severe cervical lesion at a young age (<30 years).
C1 [Vargas-Torres, Sandra Liliana; Brito Macedo, Jacyara Maria] Univ Estado Rio De Janeiro, Dept Biochem, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth Avvad] Univ Estado Rio De Janeiro, Dept Pathol, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth Avvad] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Pathol, Rio De Janeiro, Brazil.
   [Klumb, Evandro Mendes] Univ Estado Rio De Janeiro, Dept Rheumatol, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [da Rocha Guillobel, Heloisa Carneiro] Univ Estado Rio De Janeiro, Dept Biophys & Biometry, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [de Camargo, Maria Jose; Russomano, Fabio Bastos] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Gynecol, Rio De Janeiro, Brazil.
RP Macedo, JMB (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Dept Biochem, Av 28 Setembro,87 Fundos 40 Andar, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM sandraly99@yahoo.com; jacyara@uerj.br
OI Vargas-Torres, Sandra Liliana/0000-0003-4019-2089
FU Research Support Foundation of the State of Rio de Janeiro -
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/170.922/2004, E-26/111.334/2011];
   National Council for Scientific and Technological Development -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [476116/2009-0]
FX The authors declare that they have no conflict of interest. This work
   was funded by the Research Support Foundation of the State of Rio de
   Janeiro - FAPERJ (E-26/170.922/2004 and E-26/111.334/2011) and the
   National Council for Scientific and Technological Development - CNPq
   (476116/2009-0).
CR Arvanitis DA, 2008, ONCOL REP, V20, P751, DOI 10.3892/or_00000070
   Bjornslett M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-454
   Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022
   Boquett JA, 2013, DIS MARKERS, V34, P41, DOI [10.3233/DMA-2012-00937, 10.1155/2013/302920]
   Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005
   Chen EY, 2010, MODERN PATHOL, V23, P1045, DOI 10.1038/modpathol.2010.85
   de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047
   Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145
   Firoz EF, 2009, CLIN CANCER RES, V15, P2573, DOI 10.1158/1078-0432.CCR-08-2678
   Fonseca-Moutinho Jose Alberto, 2011, ISRN Obstet Gynecol, V2011, P847684, DOI 10.5402/2011/847684
   Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0
   Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4
   Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656
   Hu ZB, 2007, CANCER EPIDEM BIOMAR, V16, P2717, DOI 10.1158/1055-9965.EPI-07-0634
   Hwang LY, 2009, J ADOLESCENT HEALTH, V44, P103, DOI 10.1016/j.jadohealth.2008.10.006
   Iniesta Raquel, 2005, Gac Sanit, V19, P333, DOI 10.1157/13078029
   Iwakuma T, 2003, MOL CANCER RES, V1, P993
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI 10.3322/caac.20115
   Klumb EM, 2010, LUPUS, V19, P1485, DOI 10.1177/0961203310372952
   Knappskog S, 2014, TUMOR BIOL, V35, P6185, DOI 10.1007/s13277-014-1910-4
   Knappskog S, 2012, EUR J CANCER, V48, P1988, DOI 10.1016/j.ejca.2011.10.024
   Knappskog S, 2011, TRANSCR-AUSTIN, V2, P207, DOI 10.4161/trns.2.5.16813
   Knappskog S, 2011, ONCOTARGET, V2, P251
   Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019
   LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174
   Liu JH, 2004, GYNECOL ONCOL, V94, P803, DOI 10.1016/j.ygyno.2004.06.005
   Liu J, 2011, ASIAN PAC J CANCER P, V12, P1899
   Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710
   Meissner RD, 2007, CANCER DETECT PREV, V31, P371, DOI 10.1016/j.cdp.2007.09.001
   Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
   Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138
   Nunobiki O, 2010, GYNECOL ONCOL, V118, P258, DOI 10.1016/j.ygyno.2010.05.009
   Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6
   Ryan BM, 2012, INT J CANCER, V131, P2710, DOI 10.1002/ijc.27573
   Singhal P, 2013, DNA CELL BIOL, V32, P19, DOI 10.1089/dna.2012.1718
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Ueda M, 2009, HUM CELL, V22, P49, DOI 10.1111/j.1749-0774.2009.00068.x
   Vargas-Torres SL, 2014, BIOMARKERS, V19, P121, DOI 10.3109/1354750X.2014.881419
   Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009
   Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62
   Wo XM, 2011, J GENET GENOMICS, V38, P341, DOI 10.1016/j.jgg.2011.07.005
   Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107
   Yu HP, 2011, MOL CARCINOGEN, V50, P697, DOI 10.1002/mc.20806
   Zhao EJ, 2012, MOL BIOL REP, V39, P3471, DOI 10.1007/s11033-011-1119-1
   Zhuo WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041546
   Zhuo XL, 2014, TUMOR BIOL, V35, P5331, DOI 10.1007/s13277-014-1695-5
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 47
TC 6
Z9 6
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-750X
EI 1366-5804
J9 BIOMARKERS
JI Biomarkers
PD DEC
PY 2014
VL 19
IS 8
BP 637
EP 645
DI 10.3109/1354750X.2014.962614
PG 9
WC Biotechnology & Applied Microbiology; Toxicology
SC Biotechnology & Applied Microbiology; Toxicology
GA AU3FO
UT WOS:000345498100003
PM 25271042
DA 2020-12-01
ER

PT J
AU Vargas-Torres, SL
   Portari, EA
   Klumb, EM
   Guillobel, HCD
   de Camargo, MJ
   Russomano, FB
   Macedo, JMB
AF Vargas-Torres, Sandra Liliana
   Portari, Elyzabeth Avvad
   Klumb, Evandro Mendes
   da Rocha Guillobel, Heloisa Carneiro
   de Camargo, Maria Jose
   Russomano, Fabio Bastos
   Brito Macedo, Jacyara Maria
TI Association of CDKN2A polymorphisms with the severity of cervical
   neoplasia in a Brazilian population
SO BIOMARKERS
LA English
DT Article
DE Cervical lesion; haplotypes; p16(INK4a); p14(ARF); SNPs; susceptibility
ID COLORECTAL-CANCER; CLINICAL-COURSE; MESSENGER-RNA; CYCLIN D1;
   P16(INK4A); VARIANTS; GENE; HPV; EXPRESSION; REGION
AB Variants of p16(INK4a) and p14(ARF), encoded by the CDKN2A locus, may respond differently to the presence of human papillomavirus (HPV). We investigated the potential association of two CDKN2A polymorphisms, 500C>G (rs11515) and 540C>T (rs3088440), with cervical neoplasia in patients with cervical lesions and healthy controls (n = 492). Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), single-strand conformation polymorphism (SSCP) and/or DNA sequencing techniques were employed for genotyping. The 500G allele was found higher, whereas the 540T/T genotype was less frequent in patients with more severe lesions. The CDKN2A variants may have the potential to be markers for the management of patients with cervical neoplasia.
C1 [Vargas-Torres, Sandra Liliana; Brito Macedo, Jacyara Maria] State Univ Rio de Janeiro UERJ, Dept Biochem, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] State Univ Rio de Janeiro UERJ, Dept Pathol, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] Fiocruz MS, Fernandes Figueira Inst, Dept Pathol, BR-21045900 Rio De Janeiro, Brazil.
   [da Rocha Guillobel, Heloisa Carneiro] Univ Estado Rio De Janeiro, Dept Biophys & Biometry, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [de Camargo, Maria Jose; Russomano, Fabio Bastos] Fiocruz MS, Fernandes Figueira Inst, Dept Gynecol, BR-21045900 Rio De Janeiro, Brazil.
RP Macedo, JMB (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Dept Biochem, Av 28 Setembro,87 Fundos 4, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM jacyara@uerj.br
OI Vargas-Torres, Sandra Liliana/0000-0003-4019-2089
FU Research Support Foundation of the State of Rio de Janeiro -
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/170.922/2004, E-26/111.334/2011];
   National Council for Scientific and Technological Development -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [476116/2009-0]
FX The authors declare no conflict of interest. This study was funded by
   the Research Support Foundation of the State of Rio de Janeiro - FAPERJ
   (E-26/170.922/2004 and E-26/111.334/2011) and the National Council for
   Scientific and Technological Development - CNPq (476116/2009-0).
CR Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083
   Silva GAE, 2010, CAD SAUDE PUBLICA, V26, P2398
   Bahnassy AA, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-4
   Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005
   Chansaenroj J, 2013, ASIAN PAC J CANCER P, V14, P341, DOI 10.7314/APJCP.2013.14.1.341
   Chen EY, 2010, MODERN PATHOL, V23, P1045, DOI 10.1038/modpathol.2010.85
   Chen JY, 2007, CLIN CANCER RES, V13, P3100, DOI 10.1158/1078-0432.CCR-06-2319
   Chen JY, 2009, CANCER CAUSE CONTROL, V20, P1769, DOI 10.1007/s10552-009-9416-x
   Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211
   de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007
   Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145
   Geddert H, 2005, J CANCER RES CLIN, V131, P803, DOI 10.1007/s00432-005-0021-4
   Horn LC, 2008, AM J SURG PATHOL, V32, P502, DOI 10.1097/PAS.0b013e31815ac420
   *INCA, 2011, EST 2012 INC CANC BR
   Iniesta Raquel, 2005, Gac Sanit, V19, P333, DOI 10.1157/13078029
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI 10.3322/caac.20115
   Jin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049361
   Klumb EM, 2010, LUPUS, V19, P1485, DOI 10.1177/0961203310372952
   Kumar R, 2001, INT J CANCER, V95, P388, DOI 10.1002/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6
   LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174
   Lamperska KM, 2007, ACTA BIOCHIM POL, V54, P119, DOI 10.18388/abp.2007_3277
   Lin SC, 2000, J ORAL PATHOL MED, V29, P159, DOI 10.1034/j.1600-0714.2000.290403.x
   Litjens RJNTM, 2014, HUM PATHOL, V45, P221, DOI 10.1016/j.humpath.2013.10.014
   Maccioni L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-325
   McCloud JM, 2004, INT J ONCOL, V25, P1447
   Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005
   Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886
   Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
   Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138
   ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766
   Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640
   Pinto Alvaro P, 2010, Diagn Histopathol (Oxf), V16, P445
   Pjanova D, 2007, MELANOMA RES, V17, P185, DOI 10.1097/CMR.0b013e328014a2cd
   Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931
   Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6
   Redman R, 2008, ARCH PATHOL LAB MED, V132, P795, DOI 10.1043/1543-2165(2008)132[795:TUOPID]2.0.CO;2
   Russo AA, 1998, NATURE, V395, P237
   Sakano S, 2003, INT J CANCER, V104, P98, DOI 10.1002/ijc.10919
   Sauroja I, 2000, GENE CHROMOSOME CANC, V28, P404, DOI 10.1002/1098-2264(200008)28:4<404::AID-GCC6>3.0.CO;2-P
   Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Thakur N, 2012, MOL BIOL REP, V39, P407, DOI 10.1007/s11033-011-0752-z
   Tuna G, 2013, DNA CELL BIOL, V32, P400, DOI 10.1089/dna.2012.1933
   von Keyserling H, 2012, MODERN PATHOL, V25, P465, DOI 10.1038/modpathol.2011.179
   Wang JL, 2005, MODERN PATHOL, V18, P629, DOI 10.1038/modpathol.3800308
   Yan L, 2008, INT J GYNECOL CANCER, V18, P30, DOI 10.1111/j.1525-1438.2007.00953.x
   Zheng YX, 2002, CANCER EPIDEM BIOMAR, V11, P640
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 48
TC 8
Z9 8
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-750X
EI 1366-5804
J9 BIOMARKERS
JI Biomarkers
PD MAR
PY 2014
VL 19
IS 2
BP 121
EP 127
DI 10.3109/1354750X.2014.881419
PG 7
WC Biotechnology & Applied Microbiology; Toxicology
SC Biotechnology & Applied Microbiology; Toxicology
GA AF9SR
UT WOS:000335055400004
PM 24491138
DA 2020-12-01
ER

PT J
AU Portari, EA
   Russomano, FB
   de Camargo, MJ
   Gayer, CRM
   Guillobel, HCD
   Santos-Reboucas, CB
   Macedo, JMB
AF Portari, Elyzabeth A.
   Russomano, Fabio B.
   de Camargo, Maria J.
   Machado Gayer, Carlos R.
   da Rocha Guillobel, Heloisa C.
   Santos-Reboucas, Cintia B.
   Brito Macedo, Jacyara M.
TI Immunohistochemical Expression of Cyclin D1, p16(Ink4a), p21(WAF1), and
   Ki-67 Correlates With the Severity of Cervical Neoplasia
SO INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
LA English
DT Article
DE cervical neoplasia; human papillomavirus; cell-cycle biomarkers; tissue
   microarray
ID IMPROVES INTEROBSERVER AGREEMENT; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL
   NEOPLASIA; CELL-CYCLE; ABERRANT EXPRESSION; P53 EXPRESSION; PROEX-C;
   LESIONS; OVEREXPRESSION; PROTEINS
AB High-risk human papillomaviruses are closely associated with cervical cancer and its precursor lesions through interactions between the E6 and E7 oncoproteins and the cell-cycle regulatory proteins, such as p53 and pRb, respectively. As other molecules involved in the cell-cycle control seem to be important for human papillomavirus (HPV)-mediated cervical carcinogenesis, we have analyzed the expression of p53, p21, p16, cyclin D1, and Ki-67 and the presence of HPV (HPV pool and HPV-16) by immunohistochemical studies using tissue microarray in low squamous intraepithelial lesions (n = 50), high squamous intraepithelial lesions (n = 98), and cervical carcinoma (n = 18). We have found a significant increase in the expression of p16 and p21 (P<0.001) from low- to high-grade lesions and cancer. In contrast, cyclin D1 expression showed a significant decrease in more severe lesions (P<0.001). p16, Ki-67, p21, and p53 positivity increased with the cell-layer level and the lesion severity, with stronger correlations being observed for p16 and Ki-67. High positivity for HPV pool (96.3%) and HPV-16 (77.5%) immunostaining was detected in all cases, with an association between p16 and cyclin D1 expression and HPV-16 infection. Our tissue microarray results corroborate the usefulness of the immunohistochemical assessment of cell-cycle biomarkers in distinguishing different groups of precursor lesions of the cervix and cervical carcinoma.
C1 [Portari, Elyzabeth A.] Univ Estado Rio De Janeiro, Dept Pathol, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Machado Gayer, Carlos R.; Brito Macedo, Jacyara M.] Univ Estado Rio De Janeiro, Dept Biochem, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [da Rocha Guillobel, Heloisa C.] Univ Estado Rio De Janeiro, Dept Biophys & Biometry, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Santos-Reboucas, Cintia B.] Univ Estado Rio De Janeiro, Dept Genet, BR-20551030 Rio De Janeiro, RJ, Brazil.
   [Portari, Elyzabeth A.] Fernandes Figueira Inst Fiocruz, Dept Pathol, Rio De Janeiro, Brazil.
   [Russomano, Fabio B.; de Camargo, Maria J.] Fernandes Figueira Inst Fiocruz, Dept Gynecol, Rio De Janeiro, Brazil.
RP Macedo, JMB (corresponding author), Univ Estado Rio De Janeiro, Dept Biochem, Inst Biol, Av 28 Setembro,87 Fundos 41 Andar, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM jacyara@uerj.br
OI Santos-Reboucas, Cintia/0000-0003-4729-2373
FU Foundation of Research Support in Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/170.922/2004, E-26/171.729/2001]
FX J.M.B.M. and H.C.d.R.G. have received grants (E-26/170.922/2004 and
   E-26/171.729/2001, respectively) from the Foundation of Research Support
   in Rio de Janeiro (FAPERJ).
CR Atkins K, 2011, CANCER CYTOPATHOL, V119, P145, DOI 10.1002/cncy.20139
   Baak JPA, 2006, J CLIN PATHOL, V59, P1017, DOI 10.1136/jcp.2005.027839
   Baak JPA, 2005, AM J SURG PATHOL, V29, P1062
   Badr RE, 2008, AM J SURG PATHOL, V32A, P899, DOI 10.1097/PAS.0b013e31815bbb69
   Bae DS, 2001, GYNECOL ONCOL, V81, P341, DOI 10.1006/gyno.2001.6196
   Bahnassy AA, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-4
   Bergeron C, 2010, AM J CLIN PATHOL, V133, P395, DOI 10.1309/AJCPXSVCDZ3D5MZM
   Branca M, 2004, INT J GYNECOL PATHOL, V23, P354, DOI 10.1097/01.pgp.0000139639.79105.40
   Cho NH, 2002, YONSEI MED J, V43, P722, DOI 10.3349/ymj.2002.43.6.722
   Conesa-Zamora P, 2009, AM J CLIN PATHOL, V132, P378, DOI 10.1309/AJCPO0WY1VIFCYDC
   Pires ARC, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-14
   Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369
   Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4
   Graflund M, 2002, INT J GYNECOL CANCER, V12, P290, DOI 10.1046/j.1525-1438.2002.01113.x
   Hanprasertpong J, 2010, J OBSTET GYNAECOL RE, V36, P572, DOI 10.1111/j.1447-0756.2010.01227.x
   Horn LC, 2008, AM J SURG PATHOL, V32, P502, DOI 10.1097/PAS.0b013e31815ac420
   Hu LL, 2005, MODERN PATHOL, V18, P267, DOI 10.1038/modpathol.3800290
   Huang LW, 2012, J CLIN PATHOL, V65, P117, DOI 10.1136/jclinpath-2011-200362
   Huang LW, 2001, GYNECOL ONCOL, V83, P348, DOI 10.1006/gyno.2001.6397
   Ikuta A, 2005, CANCER DETECT PREV, V29, P528, DOI 10.1016/j.cdp.2005.09.002
   Khunamornpong S, 2008, ASIAN PAC J CANCER P, V9, P48
   Kim YT, 2005, YONSEI MED J, V46, P597, DOI 10.3349/ymj.2005.46.5.597
   Klaes R, 2002, AM J SURG PATHOL, V26, P1389, DOI 10.1097/00000478-200211000-00001
   Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174
   Kruse AJ, 2002, AM J SURG PATHOL, V26, P1501, DOI 10.1097/00000478-200211000-00013
   Lie AK, 1999, INT J GYNECOL PATHOL, V18, P5, DOI 10.1097/00004347-199901000-00002
   Little L, 2010, MODERN PATHOL, V23, P611, DOI 10.1038/modpathol.2009.178
   Lu H, 2010, EUR J GYNAECOL ONCOL, V31, P662
   Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886
   Murphy N, 2003, J CLIN PATHOL, V56, P56, DOI 10.1136/jcp.56.1.56
   Nichols GE, 1996, MODERN PATHOL, V9, P418
   Ordi J, 2009, INT J GYNECOL PATHOL, V28, P90, DOI 10.1097/PGP.0b013e31817e9ac5
   Ovestad IT, 2011, J CLIN PATHOL, V64, P303, DOI 10.1136/jcp.2010.083626
   Ozaki S, 2011, HUM PATHOL, V42, P1007, DOI 10.1016/j.humpath.2010.10.021
   Pinto AP, 2012, ACTA CYTOL, V56, P109, DOI 10.1159/000335065
   Samarawardana P, 2011, APPL IMMUNOHISTO M M, V19, P1514, DOI 10.1097/PAI.0b013e3182167c66
   Schwarz JK, 2012, INT J RADIAT ONCOL, V84, P153, DOI 10.1016/j.ijrobp.2011.11.032
   Skomedal H, 1999, GYNECOL ONCOL, V73, P223, DOI 10.1006/gyno.1999.5346
   Tosun G, 2010, EUR J GYNAECOL ONCOL, V31, P627
   Trimble CL, 2010, CANCER IMMUNOL IMMUN, V59, P799, DOI 10.1007/s00262-009-0806-4
   Tsuda H, 2003, GYNECOL ONCOL, V91, P476, DOI 10.1016/j.ygyno.2003.08.019
   Van Niekerk D, 2007, GYNECOL ONCOL, V107, pS233, DOI 10.1016/j.ygyno.2007.07.064
   Vijayalakshmi N, 2007, ONCOL RES, V16, P527, DOI 10.3727/096504007783438367
   Vinyuvat S, 2008, ASIAN PAC J CANCER P, V9, P653
   Wang JL, 2004, CLIN CANCER RES, V10, P2407, DOI 10.1158/1078-0432.CCR-03-0242
   WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1
   World Health Organization, 2010, HUM PAP REL CANC
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 48
TC 21
Z9 21
U1 1
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-1691
EI 1538-7151
J9 INT J GYNECOL PATHOL
JI Int. J. Gynecol. Pathol.
PD SEP
PY 2013
VL 32
IS 5
BP 501
EP 508
DI 10.1097/PGP.0b013e31826f5cf6
PG 8
WC Obstetrics & Gynecology; Pathology
SC Obstetrics & Gynecology; Pathology
GA 203OQ
UT WOS:000323302900010
PM 23896712
DA 2020-12-01
ER

PT J
AU De Vitto, H
   Mendonca, BS
   Elseth, KM
   Vesper, BJ
   Portari, EA
   Gallo, CVM
   Paradise, WA
   Rumjanek, FD
   Radosevich, JA
AF De Vitto, H.
   Mendonca, B. S.
   Elseth, K. M.
   Vesper, B. J.
   Portari, E. A.
   Gallo, C. V. M.
   Paradise, W. A.
   Rumjanek, F. D.
   Radosevich, J. A.
TI Part II. Mitochondrial mutational status of high nitric oxide adapted
   cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors
SO TUMOR BIOLOGY
LA English
DT Article
DE Breast cancer; Somatic mtDNA mutations; mtDNA copy number; Nitric oxide
   (NO); NADH dehydrogenase (complex I)
ID DNA MUTATIONS; CANCER; ROLES; MTDNA; HEAD; P53; PROGRESSION; FREQUENCY;
   SEQUENCE; GENOME
AB Mitochondria combine hydrogen and oxygen to produce heat and adenosine triphosphate (ATP). As a toxic by-product of oxidative phosphorylation (OXPHOS), mitochondria generate reactive oxygen species (ROS). These free radicals may cause damage to mitochondrial DNA (mtDNA) and other molecules in the cell. Nitric oxide (NO) plays an important role in the biology of human cancers, including breast cancer; however, it is still unclear how NO might affect the mitochondrial genome. The aim of the current study is to determine the role of mtDNA in the breast oncogenic process. Using DNA sequencing, we studied one breast cancer cell line as a model system to investigate the effects of oxidative stress. The BT-20 cell line was fully adapted to increasing concentrations of the NO donor DETA-NONOate and is referred to as BT-20-HNO, a high NO (HNO) cell line. The HNO cell line is biologically different from the "parent" cell line from which it originated. Moreover, we investigated 71 breast cancer biopsies and the corresponding noncancerous breast tissues. The free radical NO was able to generate somatic mtDNA mutations in the BT-20-HNO cell line that were missing in the BT-20 parent cell line. We identified two somatic mutations, A4767G and G13481A, which changed the amino acid residues. Another two point mutations were identified in the mtDNA initiation replication site at nucleotide 57 and at the 'hot spot' cytidine-rich D300-310 segment. Furthermore, the NO regulated the mtDNA copy number and selected different mtDNA populations by clonal expansion. Interestingly, we identified eight somatic mutations in the coding regions of mtDNAs of eight breast cancer patients (8/71, 11.2 %). All of these somatic mutations changed amino acid residues in the highly conserved regions of mtDNA which potentially leads to mitochondrial dysfunctions. The other two somatic mtDNA mutations in the displacement loop (D-loop) region [303:315 C(7-8)TC(6) and nucleotide 57] were distributed among 14 patients (14/71, 19.7 %). Importantly, of these 14 patients, six had mutations in the p53 gene. These results validate the BT-20 parent/HNO cell line model system as a means to study ROS damage in mtDNA, as it parallels the results found in a subset of the patient population.
C1 [De Vitto, H.; Mendonca, B. S.; Rumjanek, F. D.] Univ Fed Rio de Janeiro, IBqM, Rio De Janeiro, Brazil.
   [De Vitto, H.; Elseth, K. M.; Vesper, B. J.; Paradise, W. A.; Radosevich, J. A.] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA.
   [De Vitto, H.; Elseth, K. M.; Vesper, B. J.; Radosevich, J. A.] Jesse Brown VAMC, Chicago, IL USA.
   [De Vitto, H.; Elseth, K. M.; Vesper, B. J.; Paradise, W. A.; Radosevich, J. A.] Univ Illinois, Coll Dent, Dept Oral Med & Diagnost Sci, Chicago, IL 60612 USA.
   [Portari, E. A.] Fiocruz MS, Inst Fernandes Figueira, BR-21045900 Rio De Janeiro, Brazil.
   [Gallo, C. V. M.] Univ Estado Rio de Janeiro, IB, DECB, BR-20550011 Rio De Janeiro, Brazil.
RP Radosevich, JA (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, 801 S Paulina St, Chicago, IL 60612 USA.
EM jrados@uic.edu
OI Rumjanek, Franklin/0000-0002-6618-7096
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Ambs S, 1998, CANCER RES, V58, P334
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Bayona-Bafaluy MP, 2011, BBA-BIOENERGETICS, V1807, P643, DOI 10.1016/j.bbabio.2010.08.004
   Bentz BG, 1998, HEAD NECK-J SCI SPEC, V20, P304, DOI 10.1002/(SICI)1097-0347(199807)20:4<304::AID-HED4>3.3.CO;2-V
   Bentz BG, 1999, ANN OTO RHINOL LARYN, V108, P781, DOI 10.1177/000348949910800812
   Bentz BG, 2000, HEAD NECK-J SCI SPEC, V22, P64, DOI 10.1002/(SICI)1097-0347(200001)22:1<64::AID-HED10>3.3.CO;2-A
   BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31
   De Vitto H, 2013, TUMOR BIOL, V34, P403, DOI 10.1007/s13277-012-0564-3
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104
   Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059
   Gochhait S, 2008, INT J CANCER, V123, P2580, DOI 10.1002/ijc.23817
   Hancock JT, 2009, MOL BIOTECHNOL, V43, P162, DOI 10.1007/s12033-009-9189-1
   Heyne K, 2004, FEBS LETT, V578, P198, DOI 10.1016/j.febslet.2004.10.099
   Hung WY, 2010, BBA-GEN SUBJECTS, V1800, P264, DOI 10.1016/j.bbagen.2009.06.006
   JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392
   Koufman JA, 1997, OTOLARYNG CLIN N AM, V30, P1
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   LASFARGUES EY, 1958, J NATL CANCER I, V21, P1131
   Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110
   Moller P, 2008, CANCER LETT, V266, P84, DOI 10.1016/j.canlet.2008.02.030
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008
   Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296
   Tan DJ, 2002, CANCER RES, V62, P972
   Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020
   THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274
   Todorov IN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P962, DOI 10.1134/S000629790909003X
   Vesper BJ, 2013, TUMOR BIOL, V34, P203, DOI 10.1007/s13277-012-0530-0
   Vesper BJ, 2010, TUMOR BIOL, V31, P267, DOI 10.1007/s13277-010-0028-6
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   WARBURG O, 1956, SCIENCE, V124, P269
   Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104
NR 47
TC 6
Z9 6
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD FEB
PY 2013
VL 34
IS 1
BP 337
EP 347
DI 10.1007/s13277-012-0555-4
PG 11
WC Oncology
SC Oncology
GA 075HM
UT WOS:000313875400040
PM 23238816
DA 2020-12-01
ER

PT J
AU Llerena, JC
   Horovitz, DDG
   Villar, MA
   Costa, AT
   Lima, MAFD
   Magalhaes, TSPC
   Portari, EA
   Gomes, EA
   Marie, SKN
AF Llerena, J. C., Jr.
   Horovitz, D. D. G.
   Villar, M. A.
   Costa, A. T.
   Lima, M. -A. F. D.
   Magalhaes, T. S. P. C.
   Portari, E. A.
   Gomes, E. A.
   Marie, S. K. N.
TI Autopsy findings in 2 early-onset Pompe disease crim-negative patients
   on enzyme replacement therapy
SO CLINICAL THERAPEUTICS
LA English
DT Meeting Abstract
CT 2nd European Symposium on Steps Forward in Pompe Disease
CY NOV 09-10, 2007
CL Nice, FRANCE
C1 [Llerena, J. C., Jr.; Horovitz, D. D. G.; Villar, M. A.; Costa, A. T.; Lima, M. -A. F. D.; Magalhaes, T. S. P. C.] Fiocruz MS, IFF, Ctr Genet Med, BR-21045900 Rio De Janeiro, Brazil.
   [Portari, E. A.; Gomes, E. A.] Fiocruz MS, IFF, Anat Patol, BR-21045900 Rio De Janeiro, Brazil.
   [Marie, S. K. N.] Fiocruz MS, IFF, Neurol FAPESP, Rio De Janeiro, Brazil.
   [Marie, S. K. N.] FAPESP, Sao Paulo, Brazil.
RI Marie, Suely Kazue Nagahashi/D-1870-2012
OI Marie, Suely Kazue Nagahashi/0000-0003-4419-7928
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
J9 CLIN THER
JI Clin. Ther.
PY 2008
VL 30
SU A
BP S31
EP S31
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 280ZZ
UT WOS:000254467000036
DA 2020-12-01
ER

PT J
AU Costa, AMA
   Maximiano, EBB
   Avvad-Portari, E
   Jesus, NR
   Levy, RA
   Portoa, LC
AF Costa, AMA
   Maximiano, EBB
   Avvad-Portari, E
   Jesus, NR
   Levy, RA
   Portoa, LC
TI Contractile cells and fibrillin-1 distribution is disturbed in terminal
   villi of placentae from patients with preeclampsia and systemic lupus
   erythematosus
SO PLACENTA
LA English
DT Article
DE preeclampsia; systemic erythematosus lupus; contractile cells;
   fibrillin-1; alpha-smooth muscle actin; terminal villi
ID EXTRACELLULAR-MATRIX; ELASTIC FIBERS; PERICYTES; SHEATH; LOCALIZATION;
   MICROFIBRILS; ASSOCIATION; EXPRESSION; COMPONENT; PRESSURE
AB Placentae from patients with preeclampsia (PE) and systemic lupus erythematosus (SLE) present many alterations that may impair materno-fetal exchange. We investigated the distribution of contractile cells and fibrillin-1 in terminal villi of term placentae from patients with PE or SLE and compared to control placentae. Stroma in terminal villi exhibited intense labelling for fibrillin-1. The fibrillin-1 villi surface fraction was greater in PE and SLE placentae than in controls (13 +/- 0.4%, 14 +/- 0.5%, 10 +/- 0.4%; p = 0.0001). Immunohistochemistry for alpha-smooth muscle (SM) actin showed few contractile cells in control terminal villi stroma, localized around fetal capillaries and showed rare processes in vasculo-syncytial membrane. PE and SLE placentae exhibited an increase in the number of capillaries presenting alpha-SM actin adventitial positive cells. The presence of alpha-SM actin processes interposed in the vasculo-syncytial membrane was greater in SLE villi than in PE and controls. Ultrastructural observations confirmed in SLE and PE terminal villi the presence of these processes in vasculo-syncytial membrane and also showed a thickened trophoblastic basement membrane. The present study demonstrates that an important myofibroelastic system is present in term terminal villi, and that this system is actively remodelled in PE and SLE placentae. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Dept Histol & Embryol, BR-20550170 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Sch Med Sci, BR-20550170 Rio De Janeiro, RJ, Brazil.
RP Costa, AMA (corresponding author), Univ Fed Rio de Janeiro, Dept Histol & Embryol, Rua Prof Manoel Abreu 444-3 Andar, BR-20550170 Rio De Janeiro, RJ, Brazil.
EM amacosta@uerj.br
RI Monte-Alto-Costa, Andrea/C-5224-2013; Porto, Luis Cristovao/U-6499-2019;
   Porto, Luis Cristovao/I-2984-2013; Levy, Roger A/K-3087-2014
OI Monte-Alto-Costa, Andrea/0000-0001-6572-7882; Porto, Luis
   Cristovao/0000-0003-1499-1821; Porto, Luis
   Cristovao/0000-0003-1499-1821; Levy, Roger A/0000-0001-6393-6031
CR Benirschke K, 2000, PATHOLOGY HUMAN PLAC
   Bozzola J. J., 1998, ELECT MICROSCOPY PRI
   BRANCH DW, 1989, OBSTET GYNECOL, V73, P541
   Brosens I A, 1972, Obstet Gynecol Annu, V1, P177
   CHAKRAVARTHY U, 1995, CURR EYE RES, V14, P285, DOI 10.3109/02713689509033528
   Chen CP, 2003, PLACENTA, V24, P316, DOI 10.1053/plac.2002.0904
   Costa A. M. A., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P231
   Costa AMA, 1999, AM J PATHOL, V155, P1671, DOI 10.1016/S0002-9440(10)65482-X
   CUNNINGHAM FG, 2001, WILLIAMS OBSTETRICS
   Dubreuil G, 1932, CR SOC BIOL, V111, P170
   Graf R, 1997, CELL TISSUE RES, V290, P601, DOI 10.1007/s004410050965
   Graf R, 1996, CELL TISSUE RES, V283, P133
   GRAF R, 1995, PLACENTA, V16, P57, DOI 10.1016/0143-4004(95)90081-0
   GRAF R, 1994, ANAT EMBRYOL, V190, P541
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   JACOBSON SL, 1995, J SOC GYNECOL INVEST, V2, P686, DOI 10.1016/1071-5576(95)97405-6
   KARIMU AL, 1994, BRIT J OBSTET GYNAEC, V101, P57, DOI 10.1111/j.1471-0528.1994.tb13011.x
   KAUFMANN P, 1985, ANAT EMBRYOL, V173, P203, DOI 10.1007/BF00316301
   Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977
   Kielty CM, 2002, J CELL SCI, V115, P2817
   King BF, 1997, MICROSC RES TECHNIQ, V38, P42
   Kohnen G, 1996, HISTOCHEM CELL BIOL, V105, P415, DOI 10.1007/BF01457655
   Levy RA, 1998, LUPUS, V7, pS81, DOI 10.1177/096120339800700218
   LOCKSHIN MD, 1985, NEW ENGL J MED, V313, P152, DOI 10.1056/NEJM198507183130304
   NEHLS V, 1991, J CELL BIOL, V113, P147, DOI 10.1083/jcb.113.1.147
   Rahman A, 2003, ARTHRITIS RES THER, V5, P160, DOI 10.1186/ar767
   SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499
   Sherratt MJ, 2001, MICRON, V32, P185, DOI 10.1016/S0968-4328(99)00082-7
   Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Vettraino IM, 1996, PLACENTA, V17, P557, DOI 10.1016/S0143-4004(96)80072-5
NR 31
TC 3
Z9 5
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB-MAR
PY 2006
VL 27
IS 2-3
BP 234
EP 243
DI 10.1016/j.placenta.2005.02.018
PG 10
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 004BW
UT WOS:000234728000015
PM 16338469
DA 2020-12-01
ER

PT J
AU Avvad-Portari, E
   Jesus, NR
   Levy, RA
   Desouzart, FC
   Carvalho, AG
   Morais, MS
   Costa, AMA
   Ataide, KS
   Porto, LC
AF Avvad-Portari, E
   Jesus, NR
   Levy, RA
   Desouzart, FC
   Carvalho, AG
   Morais, MS
   Costa, AMA
   Ataide, KS
   Porto, LC
TI Placental pathology in lupus and SAF patients
SO PLACENTA
LA English
DT Meeting Abstract
CT Joint Meeting of the 2nd Latinamerican Symposium on Fetal-Mateanal
   Interaction and Placenta/19th Annual Meeting of the
   Chilean-Society-of-Physiological-Sciences
CY NOV 06-09, 2005
CL Santiago, CHILE
SP Chilean Soc Physiol Sci
C1 FCM UERJ, Pathol Serv, Rio De Janeiro, Brazil.
   IBRAG UERJ, Dept Histol & Embryol, BR-20550190 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2006
VL 27
IS 1
BP A45
EP A45
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 993YM
UT WOS:000233996200156
DA 2020-12-01
ER

PT J
AU Avvad-Portari, E
   Costa, AMA
   Santana, RGS
   Bottino, NG
   Levy, RA
   Jesus, NR
   Porto, LC
AF Avvad-Portari, E
   Costa, AMA
   Santana, RGS
   Bottino, NG
   Levy, RA
   Jesus, NR
   Porto, LC
TI Placental pathology in lupus patients
SO PLACENTA
LA English
DT Meeting Abstract
CT Joint Meeting of the 2nd Latinamerican Symposium on Fetal-Mateanal
   Interaction and Placenta/19th Annual Meeting of the
   Chilean-Society-of-Physiological-Sciences
CY NOV 06-09, 2005
CL Santiago, CHILE
SP Chilean Soc Physiol Sci
C1 FCM UERJ, Pathol Serv, Rio De Janeiro, Brazil.
   IBRAG UERJ, Dept Histol & Embryol, BR-20550170 Rio De Janeiro, Brazil.
   FCM UERJ, Rheumatol Serv, Rio De Janeiro, Brazil.
   FCM UERJ, Serv Obstet, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2006
VL 27
IS 1
BP A45
EP A45
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 993YM
UT WOS:000233996200157
DA 2020-12-01
ER

EF